UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the fiscal year ended December 31, 2018

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

For the transition period from ____ to ____

 

Commission file number 000-54888

 

PURA NATURALS, INC.
(Exact name of registrant as specified in its charter)

 

Colorado 20-8496798
(State or Other Jurisdiction of  (I.R.S. Employer
Incorporation or Organization)  Identification Number)

 

23101 Lake Center Drive, Suite 100

Lake Forest, CA 92630

 (Address of principal executive offices)

 

(855) 326-8537

(Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:  NONE

 

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock, $0.001 Par Value
(Title of Each Class)
 

Indicate by check mark if the registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes     No 

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes     No 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes       No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes      No

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company", in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer   Smaller reporting company  
(Do not check if smaller reporting company)   Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes      No 

 

As of July 10, 2019, the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold was approximately $1.68 million.

 

The number of shares outstanding of each of the issuer's classes of common stock, as of July 10, 2019 is as follows:

 

               Class of Securities                                Shares Outstanding              
Common Stock, $0.001 par value   885,838,833

 

 

 

 

 

 

 

  1  
 

 

 

PURA NATURALS, INC.

 

TABLE OF CONTENTS

 

PART I
  Item 1. Business 1
  Item 1A. Risk Factors 11
  Item 1B. Unresolved Staff Comments 19
  Item 2. Properties 19
  Item 3. Legal Proceedings 19
  Item 4. Mine Safety Disclosures 15
     
PART II
  Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 4
  Item 6. Selected Financial Data 24
  Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 30
  Item 7A. Quantitative and Qualitative Disclosures About Market Risk 31
  Item 8. Financial Statements and Supplementary Data 31
  Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 31
  Item 9A. Controls and Procedures 32
  Item 9B. Other Information 33
PART III
  Item 10. Directors, Executive Officers and Corporate Governance 34
  Item 11. Executive Compensation 37
  Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 43
  Item 13. Certain Relationships and Related Transactions, and Director Independence 44
  Item 14. Principal Accounting Fees and Services 46
PART IV
  Item 15. Exhibits, Financial Statement Schedules 47
SIGNATURES 48
FINANCIAL STATEMENTS F-1
         

 

 

 

 

 

  2  
 

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Statements contained in this annual report include "forward-looking statements" within the meaning of such term in Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause actual financial or operating results, performances or achievements expressed or implied by such forward-looking statements not to occur or be realized. Forward-looking statements made in this annual report generally are based on our best estimates of future results, performances or achievements, predicated upon current conditions and the most recent results of the companies involved and their respective industries. Forward-looking statements may be identified by the use of forward-looking terminology such as "may", "will", "could", "should", "project", "expect", "believe", "estimate", "anticipate", "intend", "continue", "potential", "opportunity" or similar terms, variations of those terms or the negative of those terms or other variations of those terms or comparable words or expressions. Potential risks and uncertainties include, among other things, such factors as:

 

  · concentration of our customer base and fulfillment of existing customer contracts;
  · our ability to maintain pricing;
  · deterioration of the credit markets;
  · increased vulnerability to adverse economic conditions due to indebtedness;
  · competition within our industry;
  · asset impairment and other charges;
  · our identifying, making and integrating acquisitions;
  · our plans to identify and acquire products that we believe will be prospective for acquisition and development;
  · loss of key executives;
  · the ability to employ skilled and qualified workers;
  · work stoppages and other labor matters;
  · inadequacy of insurance coverage for certain losses or liabilities;
  · federal legislation and state legislative and regulatory initiatives relating to the energy industry;
  ·

costs and liabilities associated with environmental, health and safety laws, including any changes in the interpretation or

enforcement thereof;

  · future legislative and regulatory developments;
  · our beliefs regarding the future of our competitors;
  · our expectation that the demand for our products services will eventually increase; and
  · our expectation that we will be able to raise capital when we need it.

 

These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled "Risk Factors" set forth in this Annual Report on Form 10-K for the year ended December 31, 2018, any of which may cause our company's or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks may cause the Company's or its industry's actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.

 

Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in the future operating results over time except as required by law. We believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions.

 

As used in this Annual Report on Form 10-K and unless otherwise indicated, the terms "we," "us," "our," or the "Company" refer to Pura Naturals, Inc. (Colorado) and our subsidiary Pura Naturals, Inc. (Delaware).   The term "PURA" refers to our operating subsidiary, Pura Naturals, Inc. (Delaware).  Unless otherwise specified, all dollar amounts are expressed in United States dollars.

 

 

  3  
 

 

 

 

PART I

 

ITEM 1.  BUSINESS

 

Overview of Our Business

 

Pura Naturals, Inc. (the "Company") markets and sells a line of cleaning, health, beauty and marine products based on the BeBetterFoam® platform for consumer kitchen, bathroom, body and face with additional products for outdoor hobbies (fishing and boating, spas and pools), infant care and industrial use currently through our operating subsidiary Pura Naturals, Inc., a Delaware corporation ("PURA").  PURA was formed in 2013.  The inspiration for the Company's creation was the Gulf of Mexico oil spill in 2010. This massive spill released over 200 million gallons of oil along the Gulf Coast, making it one of the worst oil disasters in history. The immediate impact on the environment and wildlife was devastating.

 

The BeBetterFoam® is hydrophobic, which means it resists water which does not support bacteria growth.  PURA believes that the BeBetterFoam® also is up to 40 times stronger than the leading kitchen sponge brand.  BeBetterFoam® is a unique, proprietary polymer process technology that is protected by a trade secret, owned by PURA, and is incapable of being reverse engineered.

 

The Bath & Body line and household (including kitchen) sponges are Oleophilic which means, among other things, that it absorbs oil, grease and grime, removes impurities from skin (cleansing and applying/removing make- up), is latex-free.  PURA products are also non-toxic, contain Plant-Based/renewable resources, have a carbon-negative footprint (removes more carbon than is created), contain no petroleum by-products, use no adhesives or glues, and are infused with soap that is 100% natural, bio-degradable, sustainable, vegan, gluten-free, contains botanicals and essential oils; SLS-, Sulfate, Paraben-, and BPA- Free.

 

Pura Marine, the Marine Division of Pura Naturals, offers biologically-based oil-absorbent technologies to the commercial and consumer markets. Working alongside industrial partners, Pura Marine has developed environmentally sustainable oil spill prevention products and solutions targeted towards the marine oil transport, oil refining and trucking industries. Pura Marine also provides plant-based foam products to the recreational boating and fishing industries.

 

Sales by Product Line:   Twelve Months Ended,
    December 31, 2018
  Household and Kitchen   $ 127,970  
  Health and Beauty     235,023  
  Marine Products     14,053  
    $ 377,046  

 

Recent Developments

 

Business Developments

 

The Pura Naturals relabeling effort began in October and continues per customer and product. We relabeled the charcoal and tea tree oil face slices and have seen sales increase four fold since the implementation in October. We recently completed a line review with Target and will continue supplying products. We changed from a three pack to a two pack with a new label and the product was moved from the peg area to the traditional dump bin segment where other similar products are sold. The relocation of the product will increase the exposure for consumers. As of July 6, the changes has led to an approximate 3 fold increase in sales.

 

Grease Beast branded products

 

The Grease Beast product line was launched at the National Hardware show in May 2018. Since the launch, the brand has gained worldwide acceptance with over 293 locations in 32 States and 4 foreign countries for companies such as Ingles, ACE and True Value Hardware stores and hardware store distributor Orgill. The initial product launch was with 4 SKUs and has grown to over 24 SKUs with multiple pack size options and is currently offered on Homedepot.com.

 

 

  4  
 

 

 

 

The Company was recently approved as a vendor to sell the Company’s Grease Beast scrub pad line of products over the Lowes.com platform. The Company expects to have the Grease Beast products live and available for purchase through www.lowes.com on or before July 31, 2019.

 

The Company is in discussions with Menards® and expects to begin to receive orders for the Company’s Grease Beast scrub pad line of products within the time period of a month. According to their website, Menards® is a family-owned company started in 1958 and headquartered in Eau Claire, Wisconsin. They have more than 300 home improvement stores located in Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin and Wyoming. More information can be found at www.menards.com

 

The Company was recently approved as a vendor and shipped the initial order from Mitre 10 for the Company’s Grease Beast scrub pad line of products. According to their website, Mitre10 has been a part of New Zealand’s home improvement culture since 1974. They are New Zealand’s largest home improvement and garden retailer and continue to grow through both share of market and number of stores. Their trade business is also steadily growing with more and more trade professionals seeking to partner with them. To support this trade expansion they have expanded their supplier network in both New Zealand and overseas, steadily building upon their competitive advantage, great pricing and increased range for customers. Further information about Mitre 10 can be seen at https://www.mitre10.co.nz

 

The Company is advancing the sales reach for the Company Grease Beast scrub pad line of products through further on-line platforms and retail outlets. The Company attended the Orgill Dealer Market Show in Orlando, Florida in February as an approved vendor, achieving the most sales orders from any trade show yet for the products, and walked away with many new opportunities for further sales through Orgill, a distributor to over 7,000 hardware and home improvement stores worldwide.

 

The Company attended the Ace Hardware Show in Orlando, Florida as an approved vendor. This is the Company’s second show with Ace and product acceptance continued with 35 additional Ace store locations and reorders from existing store locations. A strong international interest was shown towards the entire product line. Inquiries from Australia (700 stores), South Africa (170 stores), Guatemala (17 stores) and additional stores in New Zealand. The ACE international representative will showcase the Grease Beast to the international clients.

 

The Grease Beast product line will soon be made available on ACENET Direct, ACE’s on line platform. ACENET Direct allows every ACE store to research and purchase the Grease Beast product line. This will expose the product line to over 5000 stores in the United States and over 400 stores internationally.

 

The Company was asked to return and attended the National Hardware Show in Las Vegas, Nevada May 7- 9. The Company launched the Grease Beast scrub pad products at the same show just last year. A bigger booth was scheduled and the Grease Beast branded products were placed through a “new product” challenge competition. The show was very successful with multiple sales representative groups seeking to represent our products and over 30 active leads from store chains to private label opportunities. Samples are being sent to two large distribution companies, one in Japan and one in South Korea.

 

A new heavy duty durable scrubber product line is planned for the end of the fourth quarter. The product line is badged the Grease Beast Pro line targeting industrial applications such as restaurants, hospitals and any industrial application requiring heavy duty scrubbing.

 

Private Label Sales and Manufacturing

 

The Company's bio-degreaser private label partnership with Laguna 3P continues with anticipated sales to police departments across the USA.  The Company has been contacted by a major barbeque related product supplier to private label the Grease Beast degreaser.  Three additional products are under development for a complete suite of products for private labeling.

 

 

 

  5  
 

 

 

 

Amazon

 

Pura Naturals strongly believes in on line sales and developed a detailed strategy to increase it's on line presence by expanding the products offered on Amazon from six to eight products and create incentive to purchase multiple products.  The Company has seen steady sales growth on Amazon, with sales increasing and we anticipate this trend to continue.  The Grease Beast product line was offered on Amazon the end of the third quarter. Three additional products are scheduled to be offered on Amazon in the next two months, a Grease Beast grill cleaning kit, an oil tray capture system with oil absorbing pads and a new Grease Beast outdoor cleaning bar.

 

Health and beauty “Tru + Pure” branded products

 

A new product line of hemp derived CBD products was developed and launched under the Tru +Pura brand.  Products include sponge infused face products and bars of soap. Additionally, a partnership was formed with Noreen Taylor of The Organic Face make-up line and Pura Naturals.  Under a new brand, Pura is launching a new make-up line infused with hemp derived CBD. Discussions are underway with a major distribution network to private label the CBD cleansing line, make-up line and create a bar soap line.

 

The Company expects to launch the brand within the next 2 months as a retail brand with distribution. In addition, the Company has had initial discussions through Company representatives with large scale distributors emphasizing multi-level marketing sales platforms to private label all the Company’s health and beauty products containing CBD.

 

Pura Marine

 

Pura Marine attended and displayed / sold products at the Newport Beach, California Boat show.  The show was very successful with over 40 starter kits sold and multiple other products sold. The Marine division is building a loyal customer base and the Fisherman Cleansing bar is gaining sales momentum with placement in over 25 fishing products related stores.  Products are also carried at three major fuel docks in Long Beach and Orange County, California.  The strategic relationship with Anglers Chronicles is growing and support continues with promotions airings on Anglers Chronicles weekly cable television shows and their radio AM830 Anglers Chronicles radio show.

 

Trademarks

In addition to the trademarks existing before 2018, the Company applied for and/or was awarded the following trademarks during 2018:  Pura Marine and the Grease Beast.  The Company has applied for the following trademarks:  Pura Clean, Puraclean, Pura Clean Club, Grease Beast logo, Pura Cleanse, Puratastic, and Tru + Pure.

 

Tax Cut and JOBS Act

 

On December 22, 2017 the Tax Cuts and JOBS Act (the "Act") was signed into law. The Act changed many aspects of U.S. corporate income taxation and included the reduction of the corporate income tax rate from 35% to 21%. The Act also included implementation of a territorial system and imposition of a one-time tax on deemed repatriated earnings of foreign subsidiaries. At December 31, 2018 we had not completed our accounting for the tax effects of enactment of the Act; however we made a reasonable estimate of the net effects on our existing deferred tax balances and the one-time transition tax. We will continue to assess our provision for income taxes as future guidance becomes available, however we do not currently anticipate significant revisions will be necessary. Any such revisions will be treated in accordance with the measurement period guidance outlined in Staff Accounting Bulletin No. 118.

 

History

 

We were incorporated on December 26, 2005, in the State of Colorado under the name "Yummieflies.com, Inc."  In March 2010 we filed an amendment to our Articles of Incorporation changing our name to "Yummy Flies, Inc."  We previously were engaged in marketing and selling of hand crafted fly fishing ties and other fishing accessories that had been developed by management.  We underwent a change of control in July 2016, following which we acquired our new, and current, business lines.  We change the Company name to Pura Naturals, Inc. in November 2016.

 

 

  6  
 

 

 

Share Exchange Agreement

 

Effective July 18, 2016 the Company, entered into that certain Share Exchange Agreement (the "Share Exchange Agreement") by and among the Company, PURA and certain shareholders of PURA (the "PURA Shareholders").  Pursuant to the Share Exchange Agreement, the Company exchanged the outstanding common and preferred stock of PURA held by the PURA Shareholders for shares of common stock of the Company on approximately a 1:4.2 basis, (after giving effect to certain share cancellations).  At closing, Robert Lee, the holder of 8,289,000 shares of the Company's common stock, agreed to their cancelation.  Other than Robert Lee, shareholders of Company's common stock held approximately 1,926,000 shares.  Also on the Closing Date, the Company issued approximately 6,267,000 shares of common stock to the PURA shareholders.   In addition, shares issuable under outstanding options of PURA were exercisable into shares of common stock of the Company, pursuant to the terms of such instruments.  The shares of PURA common stock issuable upon exercise of options were exchanged for approximately 470,000 Shares of the Company's common stock.  Immediately after closing, the holders of the majority shares of PURA common stock have exchanged their shares into a majority of the shares of the issued and outstanding shares of the Company's common stock.

 

As a result of the Share Exchange Agreement and the other transactions contemplated thereunder, PURA became a majority owned subsidiary of the Company.

 

The Name Change and Stock Split

 

On November 4, 2013, the Company filed Articles of Amendment to its Amended Articles of Incorporation (the "Articles of Amendment") with the Secretary of State of the State of Colorado effecting a 3.7 for 1 forward stock split of the Company's common stock (the "Forward Stock Split"), and increase in the authorized shares of common stock to 500,000,000 (the "Share Increase") and a name change of the Company to Pura Naturals, Inc. (the "Name Change", and together with the Forward Stock Split and Share Increase, the "Corporate Actions").

 

The Forward Stock Split did not change the value of any stockholder's shares of common stock with the par value remaining at $0.001 or any stockholder's ownership percentage of the common stock, except for minimal changes resulting from the treatment of fractional shares. We did not issue any fractional shares as a result of the Forward Stock Split. The number of shares issued to each stockholder was rounded up to the nearest whole number if, as a result of the Forward Stock Split, the number of shares owned by any stockholder would not be a whole number.

 

The Forward Stock Split proportionately increased all issued and outstanding shares of our common stock, as well as common stock underlying stock options, warrants and other common stock based equity grants outstanding and the respective exercise prices were proportionately increased in accordance with the terms of the agreements governing such securities. Shares of common stock reserved for issuance upon the conversion of our convertible notes were also proportionately reduced and the respective conversion prices were proportionately increased.

 

The Corporate Actions and the Amended Articles became effective on November 16, 2016 following compliance with notification requirements of the Financial Industry Regulatory Authority and the expiration of a 20-day waiting period following mailing of notification to shareholders of the actions taken by written consent.

 

Available Information

 

We file with the SEC our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to reports to be filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended. The public may read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, D.C. 20549, on official business days during the hours of 10 a.m. to 3 p.m. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

 

Our corporate headquarters are located at 23101 Lake Center Drive, Suite 100, Lake Forest, CA 92630.  Our telephone number is (855) 326-8537. We maintain a website at www.puranaturalsproduct.com that links to our electronic SEC filings and contains information about our subsidiaries which is not a part of this report.  All the above documents are available free of charge on our website as soon as reasonably practicable after filing such material electronically or otherwise furnishing it to the SEC

 

 

  7  
 

 

 

Industry Overview

 

Today, the global economy continues to encourage manufacturers toward adopting an environmentally conscious effort in the development of industrial and consumer products. Countries like China and the U.S. have taken the lead in this global effort by proposing criteria for businesses to become more "green." The European Union began to follow suit by requiring companies within the EU with more than 500 employees to report on environmental and sustainability issues by the end of 2016. As "going green" is continuing to be a major focal point among the business environment, the demand for earth conscious products and businesses continue to grow and be more desirable.

 

In the past, we have expanded our earth conscious strategy throughout all aspects of our business practices. This provided us with a competitive advantage by allowing ourselves to establish a presence among the environmentally conscious market space. In order to increase our market share regarding the environmentally conscious market space, we plan to increase our product awareness within the space we have already captured as a means to gain market expansion.

 

Our Products

 

We offer a diverse line of cleaning products with applications across several sectors, and are increasing our market presence in the eco-conscious cleaning product market.  We continue gain product acceptance against classic cleaning products like the kitchen sponge and Bilge Boom. We operate in four business segments: Health, Consumer, Marine, and Oil Spill Prevention.  Recent sales at "big box stores" that carry the Pura Naturals brand demonstrate that our products are gaining recognition and popularity in the U.S.  This market acceptance positions Pura Naturals to expand to other North American markets like Canada and Latin Americas. The Grease Beast brand of products have expanded to 10 foreign countries with inquires and request for quotation from 4 additional countries.

 

Our cleaning sponge technologies surpass the industry's standard for foam products.  Thus, we plan to introduce new products using our foam technologies that will target industries in which we have never before held a market share. In this regard, we plan to introduce our infused sponge products to the automobile, equine, and furniture industries to reach new customers and to increase our overall market share of the cleaning products market during 2019.

 

Pura Marine, the Marine Division of Pura Naturals, offers biologically-based oil-absorbent technologies to the commercial and consumer markets. Working alongside industrial partners, Pura Marine developed environmentally sustainable oil spill prevention products and solutions targeted towards the marine oil transport, oil refining and trucking industries. Pura Marine also provides plant-based foam products to the recreational boating and fishing industries.

 

The BeBetterFoam® is hydrophobic, which means it resists water which does not support bacteria growth.  We believe the BeBetterFoam® is also up to 40 times stronger than the leading kitchen sponge brand.  BeBetterFoam® is a unique, proprietary polymer process technology that is protected by a trade secret, completely owned by PURA through an acquisition transaction with Recovery Technologies, Inc ("AIRTech") in May 2017, and we believe this technology is incapable of being reverse engineered. Previously, those formulations had been exclusively licensed to from AIRTech to PURA. 

 

Our Suppliers

 

AIRTech is our main manufacturer/supplier s for the products branded under the name of "Pura Natural." which account for approximately 65% of our supplies in the year ended December 31, 2018. Our supplier selection was made largely to impart to the strategic alliance we built alongside AIRTech.

 

Our Customers

 

Pura Naturals products are sold through numerous distribution channels, including directly to consumer and through numerous retailers, wholesalers, brokers and distributors throughout the United States. Pura Naturals products are also available direct to consumer through our own e-commerce website, and Amazon.com. Through our on line sales we sell to many small customers along with large retail accounts.

 

 

 

  8  
 

 

 

 

The following tables set forth those customers which accounted for 10% or more of our sales in 201 8:

 

Name of Customer Sales Percentage
Amazon 62.33%
Jacent Strategic 14.38%

 

 

Sales and Marketing

 

Pura Naturals increased our sales distribution channel through the addition of new distributors and retail partnership including Target Stores, Meijer's Supermarkets, Supervalu, ACE Hardware, True Value Hardware, Ingles and HomeDepot.com. Distribution has increased through Jacent’s second warehouse location and Orgill for the hardware segment.

 

Pura Marine formed a strategic relationship with the television program Anglers Chronicles.  Our products have received significant exposure during the airing of the weekly television series.  We also attended multiple radio broadcasts hosted by Anglers Chronicles.  Pura Marine also signed agreements with representation firms in California and Texas to market its products.

 

Pura Naturals was successful in building consumer and brand awareness through several key strategic partnerships including PERMATEX, Angler Chronicles, GA Aquarium and World Food Championships. We also grew our Amazon and online sales revenues, while expanding our retail opportunities within ACE Hardware, True Value Hardware, Supervalue and Jacent Strategic Merchandising. The Company launched additional products including Pura Pro Bio Degreaser and the Grease Beast product line, which hold great potential in the all-natural degreaser and the industrial, residential and hardware channels. Increased presence and activity at trade shows have proven to be a successful marketing tool increasing our store presence

 

We believe that consumers care more about what solutions the product provided rather then what the brand represented. With the knowledge and understanding we acquired from our targeted consumers, we felt it was necessary to make a change in our marketing efforts by focusing more on utilizing social media. Since the start of 2018, we have noticed a gradual increase in the demand for our products as we began to acquire more reorders from key vendors. The face slice charcoal and tea tree cleansing product label was updated in October 2018 and since the update we have seen a 4 fold increase in orders. The Grease Beast label is a new design and appears to be communicating the product attributes well with consumers

 

Competition

 

In the household market, Pura Naturals competes directly with 3M which holds a majority of the market share and owns Scotch-Brite® Scour Pads, Scotch-Brite® Scrub Sponges and O-Cel-O™ Sponges.  The bright yellow and green Scotch Brite sponge is one of the most recognizable products on market While Pura Naturals products cater more towards the environmentally conscious consumers, the 3M's distribution channels are well carved out, and they have familiarity from retailers and consumers alike. The bright yellow and green Scotch Brite sponge is one of the most recognizable products on market. For the Pura Natural Health, Beauty and Skin care products, primary competitors are from the Proctor & Gamble and Unilever brands of products.  The Marine division's primary competitor is 3M.

 

Increased competition could reduce our operating margins, profitability and result in a loss of market share. Some of our existing and potential competitors may have competitive advantages, such as more advertising funds and broader coverage and exclusive arrangements in desirable locations. These competitors could provide a wider range of media and advertising ads, which could cause us to lose market share or reduce prices in order to compete, which could decrease our revenues, gross margins and profits. We cannot guarantee that we will be able to compete against these existing and new competitors.

 

Our Intellectual Property

 

As of December 31, 2018, we have 11 registered trademarks and no copyrights or patent rights. 

 

Trademarks we hold are: "Pura Naturals", "Better Clean | Better Planet", "Mighty Soap Sponges", "Tiny Sponge, Mighty Clean", "Pura Naturals Pet, "Pura Baby", "Pura Marine", "Pura Tips", “Grease Beast”, “Pura Clean” and “Pura Equine”.

 

 

 

  9  
 

 

 

Our Research and Development

 

No material costs have been incurred on research and development activities for 2018 and 2017.  We do not expect to incur significant research and development costs in the coming future.  All true material development is performed by the licensor.  The Company is working with AirTech to develop products infused with hemp seed oils.  Due to the chemical expertise held by individuals at both AirTech and the Company, research and development costs have been minimal.

 

Employees

 

As of December 31, 2018, the Company had 6 employees at our office located at 23101 Lake Center Drive, Suite 100, Lake Forest, CA.

 

Our employees are not represented by a labor organization or covered by a collective bargaining agreement. We believe we maintain a satisfactory working relationship with our employees and we have not experienced any significant labor disputes or work stoppage or any difficulty in recruiting staff for our operations.

 

The Company has and maintains a Qualified Employee Stock Incentive Plan as a means of alternative compensation for employees and key consultants in which distributions are made in the discretion of the Board of Directors and the Chief Executive Officer.

 

The Company provides and contributes towards medical and dental insurance for the employees. We believe we are in material compliance with the relevant laws in that particular.  In the future, the Company intends to offer employees with additional benefits, including pension or retirement plans.

 

Government Regulation

 

Manufacturing

 

The manufacturing of the Company's products takes place in California. The laws and regulations of the United States, California, and local jurisdiction where the Company's products are manufactured require certain general safety guidelines for the raw materials that are used in the Company's products, as well as for employees in the workplace.

 

The manufacturing process for the Company's products complies with "best practices", does not involve toxic materials or emissions, is effluent, involves production of PH neutral products, results in a negative carbon footprint manufacturing value, and is compliant with all known and applicable safety laws and regulations.

 

Labeling

 

The labeling of the Company's products is compliant with the laws of the United States as those laws may be applicable. None of the products made and sold by the Company constitute a food, drug or intended cosmetic governed under the United States Food and Drug Administration. The statements made on the labels of the Company's products regarding the functions of the products, the contents and volumes within the packaging, and the pricing do not conflict with any known rule or regulation and accurately reflect the nature and efficacy of the products.

 

Advertising

 

United States and California advertising laws and regulations set forth certain content requirements for advertisements in the United States and California, which include prohibitions on, among other things,  misleading content.

 

Violation of these regulations may result in penalties, including fines, confiscation of advertising income, orders to cease dissemination of the advertisements and orders to publish an advertisement correcting the misleading information.

 

The Company implemented procedures to ensure the contents of all advertisements are properly reviewed for accuracy and truthfulness prior to publication.

 

 

 

  10  
 

 

 

Environmental Matters

 

The Company's operations are subject to various environmental regulations. We believe that we are in substantial compliance with applicable laws, rules and regulations relating to the protection of the environment and that our compliance will have no material effect on our capital expenditures, earnings or competitive position.

 

ITEM 1A. RISK FACTORS

 

Risks Related to Our Company

 

There is substantial doubt about our ability to continue as a going concern.

 

We have not generated any profit from operations since our inception. We expect our operating expenses will increase over the next 12 months to continue our sales and marketing activities. Based on our average monthly expenses and current burn rate, we estimate we will need to raise an additional $1,000,000 to 3,000,000 over the next 24 months. This amount could increase if we encounter difficulties that we cannot anticipate at this time or if we acquire other businesses. As of the date of this filing, we had cash and cash equivalents of approximately $30, 00 0.  We do not expect to raise significant capital through debt financing from traditional lending sources since we are not currently generating a profit from operations. Therefore, we only expect to raise money through equity financing via the sale of our common stock or equity-linked securities such as convertible debt. If we cannot raise the money that we need in order to continue to operate our business, we will be forced to delay, scale back or eliminate some or all of our proposed operations. If any of these were to occur, there is a substantial risk that our business would fail. If we are unsuccessful in raising additional financing, we may need to curtail, discontinue or cease operations.

 

We have limited operating history of the new line of business.  As such, no assurance that we will be profitability.

 

We have a limited operating history with PURA and, accordingly, have a limited operating history on which to base an evaluation of our business. Our business must be considered in light of the risks, expenses and problems frequently encountered by companies in their early stages of development, particularly companies in new and rapidly evolving markets which involve technology. Our proposed operations are subject to all of the risks inherent in the establishment of a new business enterprise. Accordingly, the likelihood of our success must be considered in the light of the problems, expenses, difficulties, complications, and delays frequently encountered in connection with the starting and expansion of a business and the relatively competitive environment in which we will operate.

 

Unanticipated delays, expenses and other problems such as setbacks in product development, product manufacturing, and market acceptance are frequently encountered in establishing a new business such as ours. There can be no assurance that the Company will be successful in addressing such risks, and any failure to do so could have a material adverse effect on the Company's business, results of operations and financial condition.

 

Because of our limited operating history, we have limited historical financial data on which to base planned operating expenses. Accordingly, our expense levels, which are, to a large extent, variable, will be based in part on our expectations of future revenues. As a result of the variable nature of many of our expenses, we may be unable to adjust spending in a timely manner to compensate for any unexpected delays in the development and marketing of our products or any subsequent revenue shortfall. Any such delays or shortfalls will have an immediate adverse impact on our business, operating results and financial condition.

 

The Company has not achieved profitability on a quarterly or annual basis to date. To the extent that net revenue does not grow at anticipated rates or that increases in its operating expenses precede or are not subsequently followed by commensurate increases in net revenue, or that the Company is unable to adjust operating expense levels accordingly, the Company's business, results of operations and financial condition will be materially and adversely affected. There can be no assurance that the Company's operating losses will not increase in the future or that the Company will ever achieve or sustain profitability.

 

 

  11  
 

 

 

 

We may need to raise additional funds in the future that may not be available on acceptable terms or at all.

 

We may need to raise additional funds via the sale of our common stock or equity-linked securities such as convertible debt in the future to fund our business plan, for potential acquisitions or investments, or for general corporate purposes. When we issue equity or convertible debt securities to raise additional funds, our existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of our existing stockholders. If we incur additional debt, it may increase our leverage relative to our earnings or to our equity capitalization, requiring us to pay additional interest expenses. We may not be able to obtain financing on favorable terms, or at all, in which case, we may not be able to develop or enhance our products, execute our business plan, take advantage of future opportunities or respond to competitive pressures.

 

Our margins fluctuate which leads to further uncertainty in our profitability model.

 

While the Company will have the potential ability to negotiate prices that benefit its clients and affect its profitability as it garners market-share and increases its book of business, margins in the energy business are fluid, and the Company's margins vary based upon the supplier and the customer. This will lead to continued uncertainty in margins from quarter to quarter.

 

If demand for our products does not develop as expected our projected revenues and profits will be affected.

 

Our future profits are influenced by many factors, including economics, and will be predicated on a stable and/or growing market and consumption of health/beauty, cleaning and marine products. We believe, and our growth expectations assume, that the markets for our suite of products will continue to grow, that we will increase our penetration of these markets and that our anticipated revenue from selling into this market will continue to increase.

 

If our expectations as to the size of these markets and our ability to sell our products and services in this market are not correct, our revenue may not materialize and our business will be harmed. 

 

Operating results may fluctuate and may fall below expectations in any fiscal quarter.

 

Our operating results are difficult to predict and are expected to fluctuate from quarter to quarter due to a variety of factors, many of which are outside of our control. Factors that may cause our operating results to fluctuate include:

 

  · our ability to arrange financing for operations;
  · our ability to acquire products to resell to our customers;
  · changes in federal, state and local government policies and programs
  · the timing of orders where we recognize revenue on a percentage of completion basis;
  · a customer's decision to delay our work, on or other risks involved with, a particular order;
  · availability and costs of labor and equipment;
  · the addition of new customers or the loss of existing customers;
  · the size and scale of new customers;
  · our ability to control costs, including operating expenses;
  · changes in the mix of our products;
  · the length of our sales cycle;
  · the productivity and growth of our sales force;
  · changes in pricing by us or our competitors, or the need to provide discounts to win business;
  · costs related to the acquisition and integration of companies or assets;
  · general economic trends or geopolitical events such as war or incidents of terrorism; and
  · future accounting pronouncements and changes in accounting policies.

 

As a result, comparing our operating results on a period-to-period basis may not be meaningful, and you should not rely on our past results or future predictions prepared by the Company as an indication of our future performance. If our revenue or operating results fall in any period, the value of our common stock would likely decline. 

 

 

 

  12  
 

 

 

Our business is at risk if we lose key personnel or is unable to attract and integrate additional skills personnel.

 

The success of our business depends in large part on the skill of our personnel. Accordingly, it is critical that we maintain, and continue to build, a highly experienced management team and specialized workforce, including engineers, project management, and business development and sales professionals. Competition for personnel, particularly those with expertise in the consumer goods industries, is high, and identifying candidates with the appropriate qualifications can be costly and difficult. We may not be able to hire the necessary personnel to implement our business strategy given our anticipated hiring needs, or we may need to provide higher compensation or more training to our personnel than we currently anticipate.

 

In the event, we are unable to attract, hire and retain the requisite personnel and subcontractors, we may experience delays in completing orders in accordance with customer schedules and pricing, which may have an adverse effect on our financial results, harm our reputation and cause us to curtail our pursuit of new customers/orders. Further, any increase in demand for personnel may result in higher costs, which in turn may have an adverse effect on our business, financial condition and operating results and harm our relationships with our customers.

 

Our future success is particularly dependent on the vision, skills, experience and effort of our senior management team, including our executive officers and our president and chief executive officer. If we were to lose the services of any of our executive officers or key employees, our ability to effectively manage our operations and implement our strategy could be harmed and our business may suffer. 

 

We operate in a highly competitive industry and competitors may compete more effectively.

 

Many of our competitors have longer operating histories and greater resources than us, and could focus their substantial financial resources to develop a competing business model, develop products or services that are more attractive to potential customers than what we offer or convince our potential customers that they should require financing arrangements that would be impractical for smaller companies to offer. Our competitors may also offer products at prices below cost and/or devote significant sales forces to competing with us or attempt to recruit our key personnel by increasing compensation, any of which could improve their competitive positions. Any of these competitive factors could make it more difficult for us to attract and retain customers; cause us to lower our prices in order to compete, and reduce our market share and revenue, any of which could have a material adverse effect on our financial condition and operating results. We can provide no assurance that we will continue to effectively compete against our current competitors or additional companies that may enter our markets.

 

We may be unable to manage our growth effectively.

 

We expect our business and operations to expand rapidly and we anticipate that further expansion of our organization and operations will be required to achieve our expectations for future growth. In addition, in order to manage our expanding operations, we will also need to improve our management, operational and financial controls and our reporting systems and procedures. All of these measures will require significant expenditures and will demand the attention of management. If we do not continue to enhance our management personnel and our operational and financial systems and controls in response to growth in our business, we could experience operating inefficiencies that could impair our competitive position and could increase our costs more than we had planned. If we are unable to manage growth effectively, our business, financial condition and operating results could be adversely affected.

 

We plan to expand our business, in part, through future acquisitions.

 

We plan to use acquisitions of companies or assets to expand our capabilities, expand our geographic markets, add experienced management and increase our product offerings. However, we may be unable to implement this growth strategy if we cannot identify suitable acquisition candidates, reach agreement with acquisition targets on acceptable terms or arrange required financing for acquisitions on acceptable terms. In addition, the time and effort involved in attempting to identify acquisition candidates and consummate acquisitions may divert members of our management from the operations of our company.

 

Any future acquisitions could disrupt business.

 

Historically, we have not made any acquisitions as part of our growth strategy.  However, we plan to use acquisitions of companies or assets to expand our project skill-sets and capabilities, expand our geographic markets, add experienced management and increase our product and service offerings. Yet, we may be unable to implement this growth strategy if we cannot identify suitable acquisition candidates, reach agreement with acquisition targets on acceptable terms or arrange required financing for acquisitions on acceptable terms. In addition, the time and effort involved in attempting to identify acquisition candidates and consummate acquisitions may divert members of our management from the operations of our company.

 

  13  
 

 

 

 

If we are successful in consummating acquisitions, those acquisitions could subject us to a number of risks, including:

 

  · the purchase price we pay could significantly deplete our cash reserves or result in dilution to our existing stockholders;
  · we may find that the acquired company or assets do not improve our customer offerings or market position as planned;
  · we may have difficulty integrating the operations and personnel of the acquired company;
  ·

key personnel and customers of the acquired company may terminate their relationships with the acquired company as a result

of the acquisition;

  ·

we may experience additional financial and accounting challenges and complexities in areas such as tax planning and

financial reporting;

  ·

we may assume or be held liable for risks and liabilities as a result of our acquisitions, some of which we may not discover

during our due diligence or adequately adjust for in our acquisition arrangements;

  · we may incur one-time write-offs or restructuring charges in connection with the acquisition;
  ·

we may acquire goodwill and other intangible assets that are subject to amortization or impairment tests, which could result in

future charges to earnings; and

  · we may not be able to realize the cost savings or other financial benefits we anticipated.

 

These factors could have a material adverse effect on our business, financial condition and operating results.

 

We may incur a variety of costs to engage in future acquisitions of companies, products or technologies, and the anticipated benefits of those acquisitions may never be realized.

 

As a part of our business strategy, we may make acquisitions of, or significant investments in, complementary companies, products or technologies, although no acquisitions or investments are currently pending. Any future acquisitions would be accompanied by risks such as:

 

  · difficulties in assimilating the operations and personnel of acquired companies;
  · diversion of our management's attention from ongoing business concerns;
  ·

our potential inability to maximize our financial and strategic position through the successful incorporation of acquired

technology and rights into our products;

  · additional expense associated with amortization of acquired assets;
  · charges at the time of acquisitions related to the expensing of process research and development;
  · the exposure to additional debt to fund an acquisition;
  · dilution to existing shareholders should the Company raise additional equity;
  · maintenance of uniform standards, controls, procedures and policies; and
  ·

impairment of existing relationships with employees, suppliers and customers as a result of the integration of new

management personnel.

 

We cannot guarantee that we will be able to successfully integrate any business, products, technologies or personnel that we might acquire in the future, and our failure to do so would have a material adverse effect on our business, financial condition and operational results.

 

 

  14  
 

 

  

 

International operations could expose business to additional risks.

 

We expect to generate a portion of sales outside the United States in the future. International expansion and sales is one of our growth strategies, and we expect our revenue and operations outside of North America will expand in the future. These operations will be subject to a variety of risks that we do not face in the United States including:

 

  · increased travel, infrastructure and legal and compliance costs associated with multiple international locations;
  · additional withholding taxes or other taxes on our foreign income, and tariffs or other restrictions on foreign trade or investment;
  · imposition of, or unexpected adverse changes in, foreign laws or regulatory requirements, many of which differ from those in the United States;
  · increased exposure to foreign currency exchange rate risk;
  · longer payment cycles for sales in some foreign countries and potential difficulties in enforcing contracts and collecting accounts receivable;
  · difficulties in repatriating overseas earnings;
  · general economic conditions in the countries in which we operate; and
  · political unrest, war, incidents of terrorism or responses to such events.

 

Our overall success in international markets will depend, in part, on our ability to succeed in differing legal, regulatory, economic, social and political conditions. We may not be successful in developing and implementing policies and strategies that will be effective in managing these risks in each country where we do business. Our failure to manage these risks successfully could harm our international operations, reduce our international sales and increase our costs, thus adversely affecting our business, financial condition and operating results.

 

Insurance and contractual protections may not always cover lost revenue.

 

Although we possess insurance, warranties from suppliers, and subcontractors obligations to meet certain performance levels and attempt, where feasible, to pass risks we cannot control to our customers, the proceeds of such insurance, warranties, performance guarantees or risk sharing arrangements may not be adequate to cover lost revenue, increased expenses or liquidated damages payments that may be required in the future.

 

We rely on outside consultants, employees, manufacturers and suppliers.

 

We will rely on the experience of outside consultants, employees, manufacturers and suppliers. In the event that one or more of these consultants or employees terminates employment with the Company, or becomes unavailable, suitable replacements will need to be obtained and there is no assurance that such employees or consultants could be obtained under conditions favorable to us.

 

We rely on Strategic relationships to promote our products.

 

We will rely on strategic partnerships with outside companies and individuals to promote and supply certain of our products, thus making the future success of our business particularly contingent on the efforts of other parties. An important part of our strategy is to promote acceptance of our products through technology and product alliances with certain distributors who we feel could assist us with our promotion strategies. Our dependence on outside distributors, however, raises potential risks with respect to the future success of our business. Our success is dependent on the successful completion and commercial deployment of our products and services and on the future commitment of our distributors to our products and technology.

 

We rely on our suppliers.

 

We will rely on key vendors and suppliers to provide high quality products and services on a consistent basis. The Company uses outside assembly facilities and contract manufacturers to produce quantities of materials these include, manufacturing facilities, warehouses, shippers, testing facilities and other critical vendor partners. The future success of the Company is contingent on the efforts and performance of these suppliers. Although in the past we have obtained adequate quantities of raw materials and finished product on acceptable terms to meet our requirements, we may have difficulty in locating or using alternative resources should supply problems arise with the current suppliers. An interruption or reduction in the source of supply of any of the component materials, or an unanticipated increase in vendor prices, could materially affect our operating results and damage customer relationships as well as our business.

 

 

 

  15  
 

 

 

There can be no assurance that we will generate sufficient revenues to support our operation or a positive cash flow.

 

There can be no assurance that our proposed operations will result in sufficient revenues to enable us to operate at profitable levels or to generate positive cash flow. As a result of the Company's limited operating history and the nature of the markets in which it competes, the Company may not be able to accurately predict its revenues. Any failure by the Company to accurately make such predictions would have a material adverse effect on the Company's business, results of operations and financial condition. Further, the Company's current and future expense levels are based largely on its investment plans and estimates of future revenues. The Company expects operating results to fluctuate significantly in the future as a result of a variety of factors, many of which are outside of the Company's control. Factors that may adversely affect the Company's operating results include, among others, demand for the products of the Company, the budgeting cycles of potential customers, lack of enforcement of or changes in governmental regulations or laws, the amount and timing of capital expenditures and other costs relating to the expansion of the Company's operations, the introduction of new or enhanced products and services by the Company or its competitors, the timing and number of new hires, changes in the Company's pricing policy or those of its competitors, the mix of products, increases in the cost of raw materials, technical difficulties with the products, incurrence of costs relating to future acquisitions, general economic conditions, and market acceptance of the company's products. As a strategic response to changes in the competitive environment, the Company may from time to time make certain pricing, service or marketing decisions or business combinations that could have a material adverse effect on the Company's business, results of operations and financial condition. Any seasonality is likely to cause quarterly fluctuations in the Company's operating results, and there can be no assurance that such patterns will not have a material adverse effect on the Company's business, results of operations and financial condition. The Company may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall.

 

If we are unable to successfully recruit and retain qualified personnel, we may not be able to continue our operations.

 

In order to successfully implement and manage our business plan, we will depend upon, among other things, successfully recruiting and retaining qualified personnel having experience in the consumer goods industry. Competition for qualified individuals is intense. We may not be able to find, attract and retain qualified personnel on acceptable terms. If we are unable to find, attract and retain qualified personnel with technical expertise, our business operations could suffer.

 

If we fail to protect our intellectual property, our planned business could be adversely affected.

 

Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or obtain and use information that we regard as proprietary. Unauthorized use of our proprietary technology could harm our business. Litigation to protect our intellectual property rights can be costly and time-consuming to prosecute, and there can be no assurance that we will have the financial or other resources necessary to enforce or defend a patent infringement or proprietary rights violation action.

 

We may be subject to lawsuits related to products we purchase from our suppliers or the services performed by our providers.

 

In the future, we may be a party to, or may be otherwise responsible for, pending or threatened lawsuits or other claims related to products we purchase from our approved manufacturers and suppliers. We intend to require our approved providers to have product liability insurance, but there can be no assurance that such product liability insurance will be sufficient to protect us against potential liability. Additionally, there is no certainty that we will not be named in an action for product liability. Such cases and claims may raise difficult and complex factual and legal issues and may be subject to many uncertainties and complexities, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Upon resolution of any pending legal matters or other claims, we may incur charges in excess of established reserves. Product liability lawsuits and claims, safety alerts or product recalls in the future, regardless of their ultimate outcome, could have a material adverse effect on our business and reputation and on our ability to attract and retain customers and joint venture partners. Our business, profitability and growth prospects could suffer if we face such negative publicity.

 

Risks Related to Our Products

 

We face a risk of defective products and, as a result, a damaged reputation.

 

If any of our products contain defects, or have reliability, quality or compatibility problems, our reputation could be damaged significantly and customers might be reluctant to use our products, which could result in the loss of revenues. We may have to invest significant capital and other resources to correct these problems. Such expenditures to correct defects and the effect on our reputation could have a material adverse effect on the business, financial condition and results of operations of the Company.

 

  16  
 

 

 

 

We face the risk of product liability claims and uninsured losses.

 

We face an inherent business risk of exposure to product liability claims in the event that the use of our technology or products is alleged to have resulted in adverse effects. To date, no claim for damages has been asserted against the Company. There can be no assurance that liability claims will not exceed the coverage limits of any policies purchased by the Company or that such insurance will continue to be available on commercially reasonable terms or at all. If the Company does not or cannot maintain sufficient liability insurance, its ability to operate may be significantly impaired. In addition, liability claims could have a material adverse effect on the business, financial condition and results of operations of the Company.

 

We have comprehensive insurance, including liability, fire, and extended coverage. Certain losses of a catastrophic nature such as from floods, tornadoes, thunderstorms and earthquakes are uninsurable or not economically insurable. Such "Acts of God," work stoppages, regulatory actions or other causes, could interrupt operations and adversely affect our business.

 

It is incumbent upon us to keep up with technological change so that our products can maintain their demand in the marketplace.

 

There can be no assurance that our competitors will not succeed in developing or marketing products or technologies that are more effective and/or less costly and which render the Company's products obsolete or non-competitive. In addition, new technologies and procedures could be developed that replace or reduce the value of our products. Our success will depend in part on our ability to respond quickly to technological changes through the development and introduction of new products and to successfully market these products. There can be no assurance that new product development efforts will result in any commercially successful products. A failure to develop and successfully market new products could have a material adverse effect on our business, financial condition and results of operations.

 

Risks Relating to Our Common Stock

 

If we issue additional securities in the future, it will result in the dilution of our existing stockholders.

 

Our articles of incorporation authorize the issuance of up to 500,000,000 shares of our common stock, with a par value of $0.001 per share. Our board of directors may choose to issue some or all of such shares to acquire one or more companies or products and to fund our overhead and general operating requirements. The issuance of any such shares will reduce the book value per share and may contribute to a reduction in the market price of the outstanding shares of our common stock. If we issue any such additional shares, such issuance will reduce the proportionate ownership and voting power of all current stockholders. Further, such issuance may result in a change of control of our company.


Trading of our stock is restricted by the Securities Exchange Commission's penny stock regulations, which may limit a stockholder's ability to buy and sell our common stock.

 

The Securities and Exchange Commission has adopted regulations which generally define "penny stock" to be any equity security that has a market price (as defined) less than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Our securities are covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and "accredited investors". The term "accredited investor" refers generally to institutions with assets in excess of $5,000,000 or individuals with a net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the Securities and Exchange Commission, which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer's account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer's confirmation. In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe that the penny stock rules discourage investor interest in and limit the marketability of our common stock.

 

 

  17  
 

 

 

 

FINRA sales practice requirements may also limit a stockholder's ability to buy and sell our stock.

 

In addition to the "penny stock" rules described above, the Financial Industry Regulatory Authority ("FINRA") has rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer's financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our stock.

 

The price of our common stock may be negatively impacted by factors that are unrelated to our operations.

 

Although our common stock is currently listed for quotation on the OTC Markets and a market is established and trading has begun, trading through the OTCQB is frequently thin and highly volatile. There is no assurance that a sufficient market will continue in our stock, in which case it could be difficult for stockholders to sell their stock. The market price of our common stock could fluctuate substantially due to a variety of factors, including market perception of our ability to achieve our planned growth, quarterly operating results of our competitors, trading volume in our common stock, changes in general conditions in the economy and the financial markets or other developments affecting our competitors or us. In addition, the stock market is subject to extreme price and volume fluctuations. This volatility has had a significant effect on the market price of securities issued by many companies for reasons unrelated to their operating performance and could have the same effect on our common stock.

 

Because we may not be able to attract the attention of major brokerage firms, it could have a material impact upon the price of our common stock .

 

It is not likely that securities analysts of major brokerage firms will provide research coverage for our common stock since the firm itself cannot recommend the purchase of our common stock under the penny stock rules referenced in an earlier risk factor. The absence of such coverage limits the likelihood that an active market will develop for our common stock. It may also make it more difficult for us to attract new investors at times when we require additional capital.

 

Our bylaws contain provisions indemnifying our officers and directors against all costs, charges and expenses incurred by them.

 

Our bylaws contain provisions with respect to the indemnification of our officers and directors against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment, actually and reasonably incurred by them, including an amount paid to settle an action or satisfy a judgment in a civil, criminal or administrative action or proceeding to which they are made parties by reason of their being or having been our directors or officers.

 

We do not intend to pay dividends on the shares of stock of our company and any gain on an investment in our company will need to come through an increase in our stock's price, which may never happen.

 

We have never paid any cash dividends and currently do not intend to pay any dividends for the foreseeable future. To the extent that we require additional funding currently not provided for in our financing plan, our funding sources may prohibit the payment of a dividend. Because we do not intend to declare dividends, any gain on an investment in our company will need to come through an increase in the stock's price. This may never happen and investors may lose all of their investment in our company.

 

 

 

 

  18  
 

 

 

Due to factors beyond our control, our stock price may be volatile.

 

The market price for our common stock has been highly volatile at times. As long as the future market for our common stock is limited, shareholders may only be able to sell them at a loss.

 

In addition, the stock markets have experienced extreme price and volume fluctuations in recent years that have affected and continue to affect the market prices of equity securities of many technology companies. Stock prices of many such companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. These broad market fluctuations may adversely affect the trading price of our common stock. In the past, following periods of volatility in the market price of a company's securities, class action litigation has often been instituted against such company. Any litigation of this type brought against us could result in substantial costs and a diversion of our management's attention and resources, which would harm our business, operating results and financial condition.

 

We do not intend to pay dividends on any investment in the shares of common stock of our company and any gain on an investment in our common stock will need to come through an increase in our stock’s price, which may never happen.

 

We have never paid any cash dividends and currently do not intend to pay any dividends on our common stock for the foreseeable future. To the extent that we require additional funding currently not provided for in our financing plan, our funding sources may prohibit the payment of a dividend. Because we do not intend to declare dividends, any gain on an investment in our company will need to come through an increase in our common stock’s price. This may never happen and investors may lose all of their investment in our company.

 

ITEM 1B.  UNRESOLVED STAFF COMMENTS

 

None. 

 

ITEM 2.  PROPERTIES

 

We maintain our head office at 23101 Lake Center Drive, Suite 100, Lake Forest, CA 92630. The office space was provided by our affiliate, AirTech. The Company pay Airtech $10K overhead each month for office space provided and other items such as minor warehouse space, office / warehouse supplies and resource function allocation. We believe that all our property has been adequately maintained, is generally in good condition, and is suitable and adequate for our business.

 

 

ITEM 3.  LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these, or other matters, may arise from time to time that may harm our business.

 

There is one matter presently before the United States Patent and Trademark Office (USPTO), a prior Arbitration legal proceeding involving James Kordenbrock (“Kordenbrock”) has settled, and there is an attorneys’ fee dispute case between the Company and a law firm.

 

The Company is defending the Pura Naturals Pet, Pura Pet and Pura Tips trademarks in a trademark cancellation proceeding brought my Nxt Generation Pet, Inc. challenging these marks. The parties have conducted discovery and submitted evidence to the USPTO. The matter is set for hearing on the merits in December of 2019. The Company is optimistic that the Company will prevail in the cancellation dispute. However, at this time, no judicial determination has been made by the USPTO and the Company cannot state with certainty the likely outcome one way or another. The Company is confident that the adverse party will not obtain the marks in the cancellation proceeding or through separate application for the marks.

 

 

 

  19  
 

 

 

In the Arbitration between the Company and Kordenbrock, a prior officer, for breach of contract and related theories, the parties have fully settled the matter and the legal proceedings have ended. The Company is satisfied with the result obtained. The Company did not agree to pay Kordenbrock money nor did the Company receive money from Kordenbrock. The Arbitration proceedings were confidential. Settlement documents are in the possession of the Company and any requests for further information should be directed to the Company in writing.

 

The Company was named in a lawsuit in Hawaii entitled Yen, et al. v. Advanced Innovative Marketing, Inc., et al. Although the Company has not been dismissed yet from the lawsuit, the Company believes there is no merit to the case and that the Company never should have been named as a party. The Company is represented by counsel and the Company is currently seeking a full dismissal.

 

The Company and the law firm of Sheppard, Mullin, Richter and Hampton are involved in a legal proceeding in The Superior Court of the State of California concerning unpaid legal fees billed by the law firm to the Company. The Company and the law firm have discussed settlement and the Company believes a satisfactory settlement that involves an amount certain that is owed and a payment arrangement will be reached soon.

 

 

ITEM 4.   MINE SAFETY DISCLOSURES.

 

Not applicable.

 

 

 

  20  
 

 

 

 

PART II

 

ITEM 5.  

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER

PURCHASES OF EQUITY SECURITIES

 

Market for Our Common Stock

 

Since November 23, 2016, our common stock has been quoted on the OTCQB, which is part of the OTC Market Group's quotation system. We were initially traded under the symbol "YMMF" but beginning in November 2016, our stock began trading under the symbol "PNAT".

 

The following table sets forth, for the periods indicated, the high and low closing prices of our common stock. These prices reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not represent actual transactions. 

 

      Closing Prices (1)  
      High       Low  
FISCAL YEAR ENDED DECEMBER 31, 2018                
Fourth Quarter   $ 0.01     $ 0.002  
Third Quarter   $ 0.02     $ 0.004  
Second Quarter   $ 0.06     $ 0.01  
First Quarter   $ 0.24     $ 0.03  
                 
FISCAL YEAR ENDED DECEMBER 31, 2017                
Fourth Quarter   $ 0.35     $ 0.07  
Third Quarter   $ 0.77     $ 0.36  
Second Quarter   $ 1.52     $ 0.46  
First Quarter   $ 3.57     $ 1.16  

 

(1)   The above tables set forth the range of high and low closing prices per share of our common stock as reported by www.finance.yahoo.com for the periods indicated.

 

Approximate Number of Holders of Our Common Stock

 

As of December 31, 2018, the Company had approximately 121 stockholders of record at VStock Transfer Agent and 483,552,395 shares of common stock were issued and outstanding. As of July 2, 2019, the Company had approximately 175 stockholders of record at VStock Transfer Agent and 885,522,294 shares of common stock were issued and outstanding because some of our common stock is held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.

 

Our registrar and transfer agent for our common stock is VStock Transfer. It's address is 18 Lafayette, Woodmere, NY 11598, USA and their telephone number and facsimile are +1 212-828-8436and +1 646-536-3179, respectively.

 

 

  21  
 

 

 

 

 

Dividend Policy

 

The Company has not declared any dividends since incorporation and does not anticipate doing so in the foreseeable future. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business.

 

Our board of directors has discretion on whether to pay dividends unless the distribution would render us unable to repay our debts as they become due. Even if our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the board of directors may deem relevant.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

See Item 12 - Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters, "Securities Authorized for Issuance Under Equity Compensation Plans" .

 

Recent Sales of Unregistered Securities

 

From January through December 2018, the Company entered into a series of stock purchase agreements with accredited investors for the sale of 444,239,353 shares of its common stock for $1,514,633.

 

Unless otherwise set forth above, the securities described above were not registered under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state, and were offered and sold in reliance on the exemption from registration afforded by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder and corresponding provisions of state securities laws, which exempt transactions by an issuer not involving any public offering.

 

Date of issuance Shares Issued Value ($)
January 17, 2018 500,000 $ 31,875
January 31, 2018 500,000 31,875
February 5, 2018 1,773,889 75,585
March 8, 2018 1,428,571 50,000
March 16, 2018 500,000 20,325
March 27, 2018 1,000,000 25,750
April 17, 2018 1,000,000 4,260
April 18, 2018 2,000,000 21,000
April 19, 2018 2,641,249 34,054
May 2, 2018 2,300,000 9,798
May 7, 2018 936,640 17,562
May 10, 2018 1,380,379 20,000
May 22, 2018 1,000,000 12,225
May 23, 2018 2,700,000 8,802
June 5, 2018 1,000,000 11,700
June 7, 2018 2,065,291 18,000
June 12, 2018 2,750,000 21,725
June 18, 2018 4,100,000 21,410
June 22, 2018 2,058,329 17,000
July 3, 2018 2,750,000 21,313

 

 

  22  
 

 

 

 

Date of issuance Shares Issued Value ($)
July 6, 2018 3,205,759 26,395
July 16, 2018 6,450,973 15,672
July 23, 2018 1,900,000 10,260
July 26, 2018 7,001,049 25,729
July 27, 2018 4,068,841 14,241
August 6, 2018 3,500,000 10,500
August 9, 2018 2,755,172 7,990
August 10, 2018 3,162,069 9,170
August 13, 2018 3,089,655 8,960
August 14, 2018 3,286,207 9,530
August 21, 2018 5,588,889 15,090
August 22, 2018 2,843,696 7,038
August 27, 2018 5,586,957 12,850
August 28, 2018 5,590,909 12,300
August 29, 2018 3,804,545 (7,305)
August 30, 2018 12,052,273 23,215
August 31, 2018 7,925,000 8,231
September 4, 2018 4,704,366 8,468
September 6, 2018 7,744,000 4,956
September 7, 2018 12,609,494 25,075
September 10, 2018 20,575,674 38,860
September 11, 2018 7,737,500 24,760
September 12, 2018 7,740,625 24,770
September 13, 2018 3,732,051 14,555
September 14, 2018 5,248,387 16,270
September 18, 2018 38,980,049 55,373
September 25, 2018 7,716,393 15,062
September 26, 2018 11,412,156 21,911
September 27, 2018 13,000,000 10,660
October 3, 2018 29,655,587 61,011
October 4, 2018 4,224,286 12,111
October 9, 2018 11,058,397 31,185
October 11, 2018 60,000,000 203,950
October 12, 2018 15,250,000 36,600
October 19, 2018 11,554,046 20,220
October 26, 2018 50,000,000 187,500
November 1, 2018 5,100,000 17,212
  444,239,353 $                           1,514,634

 

Purchases of Our Equity Securities

 

No repurchases of our common stock were made during 2018. 

 

 

 

  23  
 

 

 

ITEM 6.  SELECTED FINANCIAL DATA

 

Smaller reporting companies are not required to provide the information required by this item.

 

 

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview and History

 

We were incorporated on December 26, 2005, in the State of Colorado under the name "Yummieflies.com Inc."  In March 2010, we filed an amendment to our Articles of Incorporation changing our name to "Yummy Flies, Inc."  In November 2016, we filed an amendment to our Articles of Incorporation changing our name to "Pura Naturals, Inc."  In September 2010, we engaged in a forward split of our issued and outstanding Common Stock whereby nine (9) shares of Common Stock were issued in exchange for every one (1) share then issued and outstanding.  In addition, in November 2016, we engaged in a forward split of our issued and outstanding Common Stock whereby 3.7 shares of Common Stock were issued in exchange for every one (1) share then issued and outstanding.  All references to our issued and outstanding Common Stock in this Report are presented on a post-forward split basis unless otherwise indicated.

 

Effective July 18, 2016, the Company entered into that certain Share Exchange Agreement by and among the Company, Pura Naturals, Inc., PURA and the PURA Shareholders.  Pursuant to the Share Exchange Agreement, the Company exchanged the outstanding common and preferred stock of PURA held by the PURA Shareholders for shares of common stock of the Company.  At closing, Robert Lee, the holder of 30,536,100 shares of common stock, agreed to cancelation of such shares.  Other than Robert Lee, shareholders of Company common stock held 7,625,700 shares.  Also at closing, the Company issued 23,187,876 shares of common stock to the PURA Shareholders.   In addition, shares issuable under outstanding options of PURA – DE will be exercisable into shares of common stock of the Company, pursuant to the terms of such instruments. 

 

As a result of the Share Exchange Agreement and the other transactions contemplated thereunder, PURA is now a wholly owned subsidiary of the Company.

 

The exchange of shares with PURA was accounted for as a reverse acquisition under the purchase method of accounting since PURA obtained control of the Company. Accordingly, the merger of PURA into the Company was recorded as a recapitalization of PURA, PURA being treated as the continuing entity. The historical financial statements presented are the financial statements of PURA.

 

PURA markets and sells a line of cleaning products based on the BeBetterFoam® platform, a revolutionary and proprietary bio-based foam, for consumer kitchen and bathroom, with additional products for outdoor hobbies (fishing and boating, spas and pools), pet care, infant care and industrial use currently under development. BeBetterFoam® is a unique, proprietary polymer process technology that is protected by a trade secret, completely owned by AIRTech and sold to PURA, and is incapable of being reverse engineered.

 

The Bath & Body line and household (including kitchen) sponges are Oleophilic which means, among other things, that it absorbs oil, grease and grime, removes impurities from skin (cleansing and applying/removing make- up), is latex-free.  PURA - DE products are also non-toxic, contain Plant-Based/ renewable resources, have a carbon-negative footprint (removes more carbon than is created), contain no petroleum by-products, use no adhesives or glues, and are infused with soap that is 100% Natural, bio-degradable, sustainable, Vegan, gluten-free, contains botanicals and essential oils; SLS-, Sulfate, Paraben-, and BPA- Free.   The BeBetterFoam® is hydrophobic, which means it resists and does not support bacteria.  PURA - DE believes that the BeBetterFoam® also is up to 40 times stronger than the leading kitchen sponge brand.

 

Pura Marine, the Marine Division of Pura Naturals, offers biologically-based oil-absorbent technologies to the commercial and consumer markets. Working alongside industrial partners, Pura Marine has developed environmentally sustainable oil spill prevention products and solutions targeted towards the marine oil transport, oil refining and trucking industries. Pura Marine also provides plant-based foam products to the recreational boating and fishing industries.

 

  24  
 

 

 

 

Results of Operations

 

Comparison of Results of Operations for the Years Ended December 31, 2018 and 2017

 

  Years Ended December 31,    
  2018 2017 Dollar Change Percentage Change
Sales                    377,046              451,381            (74,335) -16.5%
Cost of goods sold                    247,636              286,875            (39,239) -13.7%
Gross Profit                    129,410              164,506            (35,096) -21.3%
Selling expense                    375,938                73,747            302,191 409.8%
General and administrative expense                 3,147,540           4,360,432       (1,212,892) -27.8%
Interest expense               (1,208,750)         (1,399,860)            191,110 -13.7%
Gain on debt extinguishment                               -                42,855            (42,855) 100.0%
Change in fair value of derivative liabilities               (1,983,629)              646,768       (2,630,397) -406.7%
Net loss               (6,586,447)         (4,979,910)       (1,606,537) 32.3%
         

 

Sales for the year ended December 31, 2018 were $377,046, a decrease of $74,335 or 16.5% from the year ended December 31, 2017.  The decrease was due to the exit of a non-profitable customer and decreased sales to existing customers.

 

Cost of goods sold for the year ended December 31, 2018 were $247,636 a decrease of $39,239 or 13.7% from the year ended December 31, 2017.  The decrease in cost of goods was due to decreased sales. Cost of goods sold as a percentage of sales was 65.7% for 2018 compared to 63.6% for 2017.  Cost of goods sold increased as a percentage of sales due to the increase in the purchase of bulk items that are expensed and not inventoried as well as decreased cost to manufacture the product.

 

Selling expenses for the year ended December 31, 2018 were $375,938 an increase of $302,191 or 409.8% from the year ended December 31, 2017.  The increase was due to an increase in retaining outside marketing consultants and media promotions.

 

General and administrative expenses for the year ended December 31, 2018 were $3,147,540 a decrease of $1,212,892 or 27.8% from the year ended December 31, 2017.  The major components of the increase was due to:

 

  Twelve months ended December 31,
  2018 2017 Change
Payroll and payroll related expense  $       2,304,837  $       2,434,137  $    (129,300)
Commitment Fees                          -              300,000        (300,000)
Travel                15,989                24,052            (8,063)
Insurance                64,401                40,334           24,067
Professional fees:      
  Accountants                38,613              133,529          (94,916)
  Marketing/Trade Shows                15,000                80,075          (65,075)
  Edgar preparation                10,000                20,866          (10,866)
  Sales consultants                  9,300                  4,622             4,678
  Media/Website                21,596                54,873          (33,277)
  Legal              237,743                65,266         172,477
  Investor and public relations                53,592              775,412        (721,820)
  Transfer Agent                11,580                10,206             1,374
Amortization expense              100,257              101,742            (1,485)
Other General and administrative expense              264,632              315,317          (50,685)
   $       3,147,540  $       4,360,432  $ (1,212,892)

 

 

  25  
 

 

 

 

There were decreases in certain expenses:

 

· Payroll and Payroll related expenses decreased by $129,300 due to no issuance of common stock, offset by a bonus accrual under the management contracts;
· No additional Convertible Promissory Note  Commitment fee of $300,000;
· Accounting fees decreased by $94,916 due to less work performed during the quarter and year end;
· Marketing/trade show related expenses decreased $65,075 due to decreased attendance of marketing/trade shows;
· Edgar preparation fees decreased $10,866 due to less SEC filings and decreased cost of quarterly filings;
· Media/website decrease by $33,277 due to less work performed for the Company's website and creation of promotional videos;·
· Investor and public relations decreased by $721,820 due to decreased programs for Investor and Public relations and no  common shares issued for services ;
· Travel expenses decreased by $8,063 due to decreased travel by management;
· Amortization expense decreased by $1,485 due to decrease in amortization of trademarks;
· Other general and administrative expenses decreased by $50,685 due to cost reviews and controls.

 

The above decrease were offset by the following increases:

 

· Insurance expenses increased by $24,067 due to increased rates in director and officers insurance;
· Sales consultant expense increased by $4,678 due to increase use of sales consultants;
· Legal fees increased by $172,477 due to law suits and public company legal activity;
· Transfer agent expense increased by $1,374 due to increase in convertible debt conversions into common stock.

 

Interest expense for 2018 was $1,208,750 a decrease of $191,110 or 13.7% from 2017.  The decrease was mainly due to the decrease in amortization of debt discounts, prepayment penalties and interest recognized in connection with the derivative liabilities associated with the convertible notes party in for the year ended December 31, 2018 as compared to the year ended December 31, 2017.

 

Liquidity and Capital Resources

 

As of December 31, 2018, we had $29,777 in cash.

 

At December 31, 2018, we had current assets of $302,959 and current liabilities of $4,026,820 resulting in a working capital deficit of $3,723,861. We have experienced losses since our inception. This raises substantial doubt about our ability to continue as a going concern.  The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

 

Net cash used in operating activities was $689,342 during the year ended December 31, 2018, compared to $1,108,611 in net cash used during the year ended December 31, 2017.  The decrease in cash used in operating activities is due to the increase of $1,606,537 in the net loss for fiscal 2018 compared to fiscal 2017 and changes in operating assets and liabilities.

 

Cash flows used by investing activities was $2,525 during the year ended December 31,  2018 compared to cash provided by investing activities of $5,705 during the year ended December 31, 2017.  The increase in cash used by investing activities is due to trademark acquisition.

 

Cash flows provided by financing activities were $654,222 and $1,167,352 during the years ended December 31, 2018 and 2017, respectively.  The decrease in cash provided by financing activities is due to the decrease in proceeds from the issuance of convertible debt, a reduction cash received from the sale of common stock and offset by a reduction in repayment of notes payable and convertible debt during the year ended December 31, 2018 compared to the year ended December 31, 2017.  For the future, we expect to raise money through equity financing via the sale of our common stock or equity-linked securities such as convertible debt. If we cannot raise the money that we need in order to continue to operate our business, we will be forced to delay, scale back or eliminate some or all of our proposed operations.

 

 

 

  26  
 

 

 

 

Convertible Note Financings

 

On February 8, 2018, the Company issued a 12% Convertible Promissory Note #1 of $103,000, with debt issuance costs of $3,000 to an accredited investor. This convertible note is due and payable on November 20, 2018. The holder has the right from time to time, and at any time during the period beginning on the date which is 180 days following the date of the note and ending on the later of: (i) the maturity date and (ii) the date of payment of the default amount, each in respect of the remaining outstanding principal amount of this note to convert all or any amount of the outstanding and unpaid principal amount of the note into fully paid and non-assessable shares of common stock. The conversion price is 58% of the average of the lowest two trading prices for the common stock during the ten trading day period ending on the latest complete trading day prior to the conversion date.

 

 On March 5, 2018, the Company issued a 12% Convertible Promissory Note #2 of $103,000, with debt issuance costs of $3,000 to an accredited investor. This convertible promissory note #2 is due and payable on December 15, 2018. The holder has the right from time to time, and at any time during the period beginning on the date which is 180 days following the date of the note and ending on the later of: (i) the maturity date and (ii) the date of payment of the default amount, each in respect of the remaining outstanding principal amount of this note to convert all or any amount of the outstanding and unpaid principal amount of the note into fully paid and non-assessable shares of common stock. The conversion price is 61% of the average of the lowest two trading prices for the common stock during the ten trading day period ending on the latest complete trading day prior to the conversion date.

 

On March 6, 2018, the Company issued a 8% Convertible Redeemable Note of $126,000, with debt issuance costs of $6,000 to an accredited investor. This convertible note is due and payable on March 6, 2019. The holder is entitled, at its option, at any time after six months, to convert all or any amount of the principal face amount of this note then outstanding into shares of common stock. The conversion price is 60% of the lowest trading prices for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date.

 

On October 8, 2018, the Company issued two 8% Promissory Note of $50,000 each, with debt issuance costs of $1,000 each, to two accredited investor. This convertible promissory notes are due and payable on April 8, 2019. The holders has the right at any time on or after the maturity date to convert any portion of the outstanding principal and accrued interest into fully paid and non-assessable shares of common stock. The conversion price shall equal the lesser of (i) 80% of the lowest trading price for the common stock during the five trading period ending on the last completed trading day prior to the conversion date or (ii) $0.0065.

 

On November 15, 2018, the Company issued a 0% Promissory Note of $150,000, with original issue discount of $20,000 to an accredited investor. Beginning on February 15, 2019 and continuing on the 15th of every consecutive calendar month for seven months, the Company shall make a cash payment in the amount of $21,429. This convertible promissory note is due and payable on August 15, 2019. The holder has the right at any time on or after the issuance date to convert any portion of the outstanding principal and accrued interest into fully paid and non-assessable shares of common stock. The conversion price is the closing price of the closing price of the Company's common stock on the date the note is funded.

 

On October 8, 2018, the Company issued a 0% Promissory Note of $200,000 for advertising, social media, marketing, consulting, advisory and related services. This convertible promissory note is due and payable on April 8, 2019. The holder has the right at any time on or after the maturity date to convert any portion of the outstanding principal and accrued interest into fully paid and non-assessable shares of common stock. The conversion price shall equal the lesser of (i) 90% of the lowest trading price for the common stock during the five trading period ending on the last completed trading day prior to the conversion date.

 

Sale of Common Stock

 

On January 18, 2018, the Company sold $5,000 of common stock to an accredited investor. The total amount of common stock sold was 83,333 shares at $0.06 per share.

 

Note Payable

 

The Company entered into a merchant agreement on May 21, 2018. Total payments for the note payable is $40,470, which included $28,500 principal payment and $11,970 interest payment. The note payable requires daily payments of $165, is due on May 21, 2019. The loan is secured by the assets of the Company as defined by Article 9 of the Uniformed Commercial Code and a personal guaranty. The interest rate is 42% per annum.

 

 

  27  
 

 

 

 

The Company entered into a 90 day Secured Convertible Note with Bridgepoint Capital, LLC on August 10, 2018 in the principal amount of $50,000, with no interest accruing. At any time, the principal amount of the note may be converted into any funding or other agreement contemplated at a near future date between the note holder and the Company. The Convertible Note contained an original issue discount of $2,500. For the twelve months ended, $2,500 was amortized.

 

On July 10, 2018, the Company entered into a one year Unsecured Promissory Note in the principal amount of $50,000, with an interest rate of 30% per annum. Five monthly progress payments of $5,000 was due beginning on August 10, 2018. The Company made a payment of $5,000 on November 19, 2018 and December 3, 2018. The Company did not make the progress payments due on October, November and December 10, 2018. As such, this Promissory Note is in default. However, the Holder of the Promissory Note has not declared a default.

 

To date, our operations have not generated any profits.  We have funded our operating to date through the sales of common stock and issuance of notes payable and convertible notes payable.  Our ability to continue as a going concern is dependent upon use raising sufficient debt or equity capital to sustain operations until such time as we can generate a profit from our operations.    We are currently working with investors to provide us with the necessary funding, but there can be no assurances we will obtain such funding in the future.  Failure to obtain this additional financing will have a material negative impact on our ability to generate profits in the future.  We anticipate sales will increase during 2019.   As such, our anticipated cash needs to fund operations and pay our notes for the next 12 months is approximately $500,000.

 

Inflation

 

Although our operations are influenced by general economic conditions, we do not believe that inflation had a material effect on our results of operations during the year ended December 31, 2018.

 

Critical Accounting Estimates

 

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The following represents a summary of our critical accounting policies, defined as those policies that we believe are the most important to the portrayal of our financial condition and results of operations and that require management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.

 

Accounts Receivable

 

The Company grants credit to customers under credit terms that it believes are customary in the industry and does not require collateral to support customer receivables. The Company currently does not provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Normal receivable terms vary from 30-90 days after the issuance of the invoice and typically would be considered past due when the term expires. Delinquent receivables are written off based on individual credit evaluation and specific circumstances of the customer.

 

Inventory

 

Inventory is valued at the lower of the inventory's cost (first in, first out basis) or the current market price of the inventory. Management compares the cost of inventory with its market value and an allowance is made to write down inventory to market value, if lower.

 

  28  
 

 

 

 

Long-Lived Assets

 

The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment , which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal.

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers ("Topic 606"), became effective for us on January 1, 2018. Our disclosure within the below sections to this footnote reflects our updated accounting policies that are affected by this new standard. We applied the "modified retrospective" transition method for open contracts for the implementation of Topic 606. As sales are and have been primarily through distributors, and we have no significant post-delivery obligations, this did not result in a material recognition of revenue on our accompanying CFS for the cumulative impact of applying this new standard. We made no adjustments to our previously-reported total revenues, as those periods continue to be presented in accordance with our historical accounting practices under Topic 605, Revenue Recognition.

 

Deferred Income

 

In some instances, the Company receives payments prior to delivery of its products, whereupon such revenues are deferred until the revenue recognition criteria are met.

 

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation . FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the employee's requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

 

Contractual Obligations

 

Our significant contractual obligations as of December 31, 2018, are as follows:

 

    Less than One Year   One to Three Years   Three to Five Years   More than Five Years   Total
Convertible Notes   $ 1,048,323       -       -       -     $ 1,048,323  
Other notes     103,722       -       -       -       103,722  
Total   $ 1,152,045     $ -     $ -     $ -     $ 1,152,045  
                                         

 

Off-Balance Sheet Arrangements

 

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.

 

  29  
 

 

 

 

Going Concern

 

The consolidated financial statements have been prepared assuming we will continue as a going concern, which contemplates, the realization of assets and satisfaction of liabilities in the normal course of business. We incurred losses from operations of $3,394,069 and $4,269,673 for the years ended December 31, 2018 and 2017, respectively, and had an accumulated deficit of $13,912,131 at December 31, 2018. In addition, we used cash from operating activities of $689,343 for the year ended December 31, 2018.  These factors raise substantial doubt about our ability to continue as a going concern.

 

The Company will require additional funding to execute its future strategic business plan. Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue adequate to support its cost structure. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

 

While the Company is attempting to establish an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern, the Company’s cash position may not be adequate to support the Company’s daily operations. Management intends to raise additional funds by seeking equity and/or debt financing; however there can be no assurances that it will be successful in those efforts. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to obtain financing, further implement its business plan, and generate revenues.

There are significant risks and uncertainties which could negatively affect the Company’s operations. These are principally related to the existence of events of default under the Company’s outstanding debt obligations, which could trigger penalties. Furthermore, if our current indebtedness is not restructured, paid or converted into equity, which is at the debt holder’s discretion, our current operations do not generate sufficient cash to pay interest and principal on these obligations when they become due. Accordingly, there can be no assurance that we will be able to pay these or other obligations which we may incur in the future. In the event we are unable to restructure, pay or convert into equity the balance of our outstanding indebtedness, the holders may obtain judgments against us and seek to enforce such judgments against our assets, in which event we will be required to cease our business activities and the equity of our stockholders will be effectively wiped out.

Our only sources of additional funds to meet continuing operating expenses, fund additional research and development and fund additional working capital are through the sale of securities, and/or debt instruments. We are actively seeking additional debt or equity financing, but no assurances can be given that such financing will be obtained or what the terms thereof will be. We may need to discontinue a portion or all of our operations if we are unsuccessful in generating positive cash flow or financing for our operations through the issuance of securities.

 

An event of default exists under our April Note, July Note, July Note #2 ,September Notes #1 and #2 and the Promissory Note.

 

The Company was unable to repay amounts due for the April Note, July Note, July Note #2 and September Notes #1 and #2 In

addition, the Company did not make two of the progress payments due under the Promissory Note. The inability to repay represents an

event of default. The holders of the notes have not declared a default. If they were to do so, however, they would be entitled to

immediate payment of amounts far in excess of our ability to pay. Under the worst scenario, a declaration of default by the holders of

the April Note, July Note and July Note #2 could result in a liquidation of the Company and elimination of any value in our common

stock.

 

The condensed CFS do not include any adjustments related to the recoverability and classification of recorded asset amounts or the

amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Recent Accounting Pronouncements

 

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory , which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. .

 

  30  
 

 

 

 

In February 2016, the FASB issued ASU 2016-02, Leases, which will amend current lease accounting to require lessees to recognize (i) a lease liability, which is a lessee's obligation to make lease payments arising from a lease, measured on a discounted basis, and (ii) a right-of-use asset, which is an asset that represents the lessee's right to use, or control the use of, a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.

 

Management has considered all recent accounting pronouncements issued since and their potential effect on our financial statements. The Company's management believes that these recent pronouncements will not have a material effect on the Company's consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future  financial statements.

 

ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The follow discussion about our market risk disclosures involves forward-looking statements. Actual results could differ from those projected in the forward-looking statements. We are exposed to market risk related to changes in interest rates and foreign currency exchange rates. We do not use derivative financial instruments for speculative or trading purposes.

 

Interest Rate Sensitivity

 

We have no significant interest-bearing assets and our convertible promissory notes and short-term loans are fixed rate securities. Our current exposure to market risk for changes in interest rates relates primarily to the interest income generated by our cash deposits in banks and the fair value of our invested securities. Although we do not believe that interest rate has had a material impact on our financial position or results of operations to date, increase in interest rates in the future could increase interest cost on our new debt and could adversely impact our ability to refinance existing debt and limit our acquisition and development activities.

 

Foreign Currency Exchange Risk

 

We currently have no significant exposure to foreign exchange risk.

 

Inflation Risk

 

Inflationary factors such as increases in the costs to acquire advertising rights and overhead costs may adversely affect our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and selling, general and administrative expenses as a percentage of revenues if the selling prices of our services do not increase with these increased costs.

 

ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Consolidated Financial Statements

 

The financial statements required by this item begin on page F-1 hereof. 

 

ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

 

  31  
 

 

 

ITEM 9A.    CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company's reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to the Company's management, including the Company's president and chief executive officer (who is the Company's principal executive officer) and the Company's chief financial officer, treasurer, and secretary (who is the Company's principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure. In designing and evaluating the Company's disclosure controls and procedures, the Company's management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and the Company's management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. The ineffectiveness of the Company's disclosure controls and procedures was due to material weaknesses identified in the Company's internal control over financial reporting, described below.

 

Management's Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over the Company's financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act of 2002. Our management, with the participation of the Company's principal executive officer and principal financial officer has conducted an assessment, including testing, using the criteria in Internal Control - Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") (2013). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. This assessment included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of controls and a conclusion on this evaluation.

 

Based on this evaluation, the Company's management concluded its internal control over financial reporting was not effective as of December 31, 2018. The ineffectiveness of the Company's internal control over financial reporting was due to the following material weaknesses which are indicative of many small companies with small staff:

 

(i) inadequate segregation of duties consistent with control objectives; and

 

(ii) ineffective controls over period end financial disclosure and reporting processes.

 

Our management feels the weaknesses identified above have not had any material effect on our financial results. However, we are currently reviewing our disclosure controls and procedures related to these material weaknesses and expect to implement changes in the next fiscal year, including identifying specific areas within our governance, accounting and financial reporting processes to add adequate resources to potentially mitigate these material weaknesses.

 

Our management will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and is committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

 

Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

 

 

 

  32  
 

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting during the year ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within any company have been detected.

 

Management's Remediation Plan

 

We plan to take steps to enhance and improve the design of our internal control over financial reporting. During the period covered by this annual report on Form 10-K, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes in the next fiscal year as resources allow:

 

(i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management and  implement modifications to our financial controls to address such inadequacies; and

 

(ii) adopt sufficient written policies and procedures for accounting and financial reporting.

 

The remediation efforts set out in (i) is largely dependent upon our company securing additional financing to cover the costs of hiring the requisite personnel and implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

 

Management believes that despite our material weaknesses set forth above, our financial statements for the year ended December 31, 2018 are fairly stated, in all material respects, in accordance with U.S. GAAP.

 

 

ITEM 9B.    OTHER INFORMATION

 

Not applicable

 

 

 

  33  
 

 

 

 

PART III

 

ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Directors and Executive Officers

 

The following table sets forth the names, ages and positions held with respect to each Director and Executive Officer of the Company as of the date of this Annual Report.

 

 

Name Age   Position Director Since
Robert Doherty 58   Chief Executive Officer and Chairperson of the Board November 1, 2016
Robert Switzer 54   Corporate Secretary and Director November 1, 2016
Derek Duhame 54   President and Director January 12, 2017
Daniel Kryger 58   Director May 23, 2017

 

Each Director serves until our 2020 annual stockholders meeting and until their respective successors are duly elected and qualified or earlier resignation or removal.

 

Robert Doherty

 

Since February of 2014, Mr. Doherty has served as the President and then the Chief Executive Officer of Pura Naturals Inc, a publically traded company.  From April 2012 until joining Pura Naturals Inc. Mr. Doherty served as the President of ALM Tech Group a Tier I and Tier II military supplier of metal machining and advanced composite fabricated parts and assemblies.  Prior to joining ALM Tech Group. Mr. Doherty served as the President of two advanced composites armor companies LCOA Composites and ArmorStruxx.  Both companies were start-up armor suppliers.  ArmorStruxx was critical in the design and supply of composite armor for the MRAP program, supplying complete armor assemblies to Navistar Defense (MaxPro MRAP) and BAE (RG 33 MRAP).

 

Mr. Doherty earned a BSChE in Chemical Engineering from Rutgers University and an MBA from the University of Phoenix.

 

Mr. Doherty has various proprietary technical rights and 2 patents in his name.

 

Mr. Doherty is subject to a written employment agreement with the Company.

 

Robert Switzer

 

Mr. Switzer has 25 years of experience in business and executive management, with particular expertise and passion for start-ups. Through the years, Robert has gained vast experience in a wide array of business matters for companies of all sizes.

 

Mr. Switzer has been a Member of the Board of Directors and the Secretary for the Company since 2015 and became Chief Operations Officer in mid-2016.  Robert also served as executive vice president for Advanced Innovative Recovery Technologies, Inc. from early 2014 to late 2016, and thereafter served as President for approximately 12 months thereafter.

 

Mr. Switzer was President of Business Development Services Corporation from December 2012 to early 2014.

 

Prior to 2014, Mr. Switzer's experience includes work for law practices, mortgage brokerages, and as a consultant and executive business coach for a number of private and public companies.

 

Mr. Switzer's 29 years of expertise includes business start-up consulting, organizational controls, operational design, business development, intellectual property development, sales and marketing development, public relations assistance, trade secret maximization, financial forecasting and modeling, asset management, reorganizations, expansions, mergers and acquisitions, capital financing, executive management coaching, business valuations, regulatory compliance, divestitures, law, litigation, contract writing and enforcement, commercial and secured transactions, and complex dispute resolution.

 

 

  34  
 

 

 

 

As a start-up specialist, Mr. Switzer's has taken businesses from very simple beginning concepts to millions of dollars in sales. As a reorganization specialist, Mr. Switzer has restructured debt and equity, reduced liabilities, revitalized net revenue, and accomplished a total turn-around.  Typically, Mr. Switzer is able to quickly change management pathways from being stagnant or non-productive, to being profitable and providing investor returns. Robert has doubled and tripled the value of intellectual property rights for various business organizations. 

 

 Mr. Switzer's education includes a Bachelor of Science in Business Administration, with a Finance Major, from the University of Arizona in 1986. Robert completed his Post-Graduate Juris Doctor degree from the University of San Diego, School of Law in 1989.  

 

Mr. Switzer is subject to a written employment agreement with the Company.

 

Derek Duhame

 

Since November 2013 until December 2016 Mr. Duhame was the Chief Operating Officer of Impact Strategic Marketing Insights, a private marketing and sales consulting firm engaged in developing new business and growth strategies for small and medium sized companies. From October 2012 until October 2013, Mr. Duhame served as a Spinal device account manager for Altrux Medical and also attended Medical Sales College. From November 2011 until September 2012, Mr. Duhame was the Regional Sales Director, Waste Solutions for Rocktenn, a publicly held commercial cardboard and recycling company. From 1996-From January 2009 to until August 2011, Mr. Duhame was a Partner and vice president of sales for Smarter Flush Distributors, a private company that marketed and sold environmentally friendly water saving devices. From October 1996, Mr. Duhame was first a National Accounts Manager and from December 2004 until September 2008, the Vice President of DistribuTech, a division of Consumer Source, Inc., a private media publishing and distribution company.

 

Mr. Duhame received a B.S. in Business Management from Arizona State University.

 

Mr. Switzer is subject to a written employment agreement with the Company.

 

Daniel Kryger

 

Possesses over 25 years of experience in management, compliance and leadership positions.

 

Since September 2016 to present, Mr. Kryger serves as the Chief Compliance Officer, Director, Trading, supervision/Compliance & Operations for Prime Executions, Inc.  In this role, Mr. Kryger is responsible for compliance and supervision for all NYSE listed trading/sales, provides supervisory support through direct supervision, oversight and analysis of risk assessments, improvement of supervisory practices to meet today's evolving regulatory environment, responds to and work with regulatory audits and inquiries and manages buy and sell side institutional accounts.

 

From December 2015 to September 2016, Mr. Kryger was the Chief Operations Officer for Princeton Securities Group.  In this role, Mr. Kryger managed and oversaw brokerage operations and staff, supervised daily trading activity and on an ad hoc basis process trades, organize workflow, set priorities and monitor activity to ensure completion, worked with clients/staff to ensure operational questions/procedures were satisfied, ensured timeliness of client product reports/services, prepared/oversaw assignment schedules paying attention to deadlines/status and coordinate/oversee various projects throughout operational teams

 

From May 2009 to December 2016, Mr. Kryger was the Managing Director, Compliance/Supervision, Trading/Investment Banking for Benjamin & Jerold Brokerage, LLC.  Mr. Kryger was responsible for compliance/supervision for all NYSE cash equities trading and managed public and private accounts for sell side institutional equities business.

Mr. Kryger is subject to a written employment agreement with the Company.

 

Identification of Certain Significant Employees

 

We have no employees who are not executive officers, but who are expected to make a significant contribution to our business.

  

Family Relationships

 

There are no family relationships between any directors or officers of the Company.

 

 

  35  
 

 

 

Involvement in Certain Legal Proceedings

 

To the best of our knowledge, none of our directors or executive officers has, during the past ten years:

 

1. had any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;

 

2. been convicted in a criminal proceeding or is a named subject to a pending criminal (excluding traffic violations and other minor offenses);

 

3. been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities, futures, commodities or banking activities; or

 

4. been found by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission or the Commodity  Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

 

Compliance with Section 16(a) of the Exchange Act

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our executive officers, directors and beneficial owner of more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission statements of ownership and changes in ownership. The same persons are required to furnish us with copies of all Section 16(a) forms they file. We believe that, during fiscal 2018, all of our executive officers, directors and beneficial owner of more than 10% of a registered class of our equity securities complied with the applicable filing requirements.

 

In making these statements, we have relied upon examination of the copies of all Section 16(a) forms provided to us and the written representations of our executive officers, directors and beneficial owner of more than 10% of a registered class of our equity securities.

 

Code of Business Conduct and Ethics

 

A Code of Business Conduct and Ethics is a written standard designed to deter wrongdoing and to promote (a) honest and ethical conduct, (b) full, fair, accurate, timely and understandable disclosure in regulatory filings and public statements, (c) compliance with applicable laws, rules and regulations, (d) prompt reporting of violations of the code to an appropriate person and (e) accountability for adherence to the Code. We are not currently subject to any law, rule or regulation requiring that we adopt a Code of Business Conduct and Ethics. However, we have adopted a code of business conduct and ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Such code of business conduct and ethics is available on our corporate website at www.puranaturalsproducts.com .

 

Committees of Board of Directors

 

There are currently is the Compensation Committee of the Board of Directors. Our board of directors is of the view that it is appropriate for us not to have a standing nominating or audit committee because the current size of our board of directors does not facilitate the establishment of a separate committee. Our board of directors has performed, and will perform adequately, the functions of any specific committee.

 

Board Oversight of Risk

 

Our Board of Directors recognizes that, although risk management is a primary responsibility of the Company's management, the Board plays a critical role in oversight of risk. The Board, in order to more specifically carry out this responsibility, has assigned certain task focusing on reviewing different areas including strategic, operational, financial and reporting, compensation, compliance, corporate governance and other risks to the relevant Board Committees as summarized above. Each Committee then reports to the full Board ensuring the Board's full involvement in carrying out its responsibility for risk management.

 

 

  36  
 

 

 

 

ITEM 11.  EXECUTIVE COMPENSATION

 

Summary Compensation Table

 

The following table sets forth information concerning all compensation awarded to, earned by or paid during fiscal years 2018 and 2017, to the Named Executive Officers:

 

Name and Principal Position Year Salary Bonus Stock Awards ($) Options Awards ($) Non-Equity Incentive Plan Compensation ($) Change in Pension Value and Non-Qualified Deferred Compensation Earnings ($) All Other Compensation ($) Total ($)
Robert Doherty, Chief Executive Officer and Chairman 2018                   -                 -      432,696                          -                  256,245                                 -      688,941
2017                 -                 -                 -      350,975                          -                    62,500                                 -      413,475
                   
Robert Switzer, Secretary and Director 2018                 -          432,628                    230,625        663,253
2017                 -                 -                 -      350,909                          -                    56,250                                 -      407,159
                   
Derek Duhame, President 2018        92,250                 -                 -      187,476                          -                  107,750                                 -      387,476
2017        87,500                 -      246,500      138,444                          -                    27,500                                 -      499,944
                   
Daniel Kreyger, Board Member and Director of Business Development (ii) 2018        33,000             -        32,400        86,662                    -                    77,000                        -      229,062
2017        21,000             -        97,638             -                    -                      -                        -      118,638
                   
Akio Ariura, Chief Financial Officer (i) 2018        42,000             -             -             -                    -                      -                        -        42,000
2017        42,000             -             -             -                    -                      -                        -        42,000
                   
(i) Resignation as Chief Financial Officer effective December 31, 2018.  
(ii) Director of Business Development per employment agreement dated February 1, 2018  

 

(1)

As required by SEC rules, amounts in the column "Stock Awards" present the aggregate grant date fair value of awards made each year computed in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification™ 718 Compensation—Stock Compensation ("FASB ASC 718"). The grant date fair value of each of the executives' award is measured based on the closing price of our common stock on the date of grant.

 

These amounts do not reflect whether the recipient has actually realized or will realize a financial benefit from the awards. Under generally accepted accounting principles, compensation expense with respect to stock awards granted to our employees, executives and directors is generally recognized over the requisite services period. The SEC's disclosure rules previously required that we present stock award information based on the amount recognized during the corresponding year for financial statement reporting purposes with respect to these awards. However, the recent changes in the SEC's disclosure rules require that we now present stock award amounts using the grant date fair value of the awards granted during the corresponding year.

   

 

  37  
 

 

 

 

 

The number of stock awards vested to each of the Named Executive Officers for his/her service rendered in each fiscal period was summarized as follows:

 

Named Executive Officer 2017 2018
Robert Doherty 810,000 185,000
Robert Switzer 810,000 185,000
Derek Duhame 375,000 -
Daniel Kryher - 250,000
Akio Ariura - -

 

 

Currently, we do not provide any employees, including our named executive officers any company sponsored retirement benefits.

 

Employment Agreements

 

The Company has entered into employment agreements with our Named Executive Officers, except for the Chief Financial Officer as described below.

 

Each agreement provides for certain payments and benefits to the executive upon separation from us as described below in "Potential Payments Upon Termination or Change in Control." Each agreement also contains certain restrictive covenants for our benefit and requires the executive to maintain the confidentiality of our confidential information. The equity awards described in each agreement will be subject to such other terms as set forth in the employment agreements.

 

Robert Doherty

 

On October 1, 2017, as the Company's Chief Executive Officer, the Company, entered into an employment agreement with Mr. Doherty. The term of the employment agreement will expire on October 1, 2022. The term will thereafter automatically extend for successive one-year periods, but Mr. Doherty's employment may at any time be terminate in accordance with provisions within the employment agreement.  Pursuant to his employment agreement, Mr. Doherty will receive an annual base salary of $250,000.  Mr. Doherty at his option may defer base salary which will accrue interest at 10% per annum, and shall, upon Mr. Doherty's written request to the Board, be convertible into options for shares of common stock of the Company on a quarterly basis, where the conversion shall be equal to a 25% to the market price of the Company's shares at the time of the conversion, and where each option's strike price shall be at $.001 per share.

 

Mr. Doherty shall be eligible to participate in the Company's common stock incentive plan as in effect from time to time.  As of October 1, 2017 ("Effective Date"), the Compensation Committee of the Board of Directors has granted Mr. Doherty, 500,000 shares of stock in the Company at par value of $.001 which shall be issued upon execution the agreement, and 2,500,000 stock options at a purchase price of $.001 per share with a vesting schedule as follows: 25% of the options shall vest immediately upon the effective date, 25% of the options shall vest upon the Company reaching $1,000,000 in aggregate total sales revenue earned after the effective date, 25% of the options shall vest upon the Company reaching $2,000,000 in aggregate total sales revenue earned after the effective date, and the remaining unvested shares shall vest upon the Company reaching $3,000,000 in sales revenue earned after the effective date. The Company may grant Mr. Doherty additional stock options, restricted stock units or other awards under the Company's common stock incentive plan based on individual and Company performance criteria to be established by the Board.

 

Robert Switzer

 

On October 1, 2017, the Company, entered into an employment agreement with Mr. Switzer. The term of the employment agreement will expire on October 1, 2022. The term will thereafter automatically extend for successive one-year periods, but Mr. Switzer's's employment may at any time be terminate in accordance with provisions within the employment agreement.  Pursuant to his employment agreement, Mr. Switzer's will receive an annual base salary of $225,000.  Mr. Switzer's at his option may defer base salary which will accrue interest at 10% per annum, and shall, upon Mr. Switzer's written request to the Board, be convertible into options for shares of common stock of the Company on a quarterly basis, where the conversion shall be equal to 25% to the market price of the Company's shares at the time of the conversion, and where each option's strike price shall be at $.001 per share.

 

 

  38  
 

 

 

Mr. Switzer shall be eligible to participate in the Company's common stock incentive plan as in effect from time to time.  As of October 1, 2017, the Compensation Committee of the Board of Directors has granted Mr. Switzer, 500,000 shares of stock in the Company at par value of $.001 which shall be issued upon execution the agreement, and 2,500,000 stock options at a purchase price of $.001 per share with a vesting schedule as follows: Twenty-Five Percent (25%) of the options shall vest immediately upon the effective date, 25% of the options shall vest upon the Company reaching $1,000,000 in aggregate total sales revenue earned after the effective date, 25% of the options shall vest upon the Company reaching $2,000,000 in aggregate total sales revenue earned after the effective date, and the remaining unvested shares shall vest upon the Company reaching $3,000,000 in sales revenue earned after the effective date. The Company may grant Mr. Switzer additional stock options, restricted stock units or other awards under the Company's common stock incentive plan based on individual and Company performance criteria to be established by the Board.

 

Derek Duhame

 

On October 1, 2017, the Company, entered into an employment agreement with Mr. Duhame. The term of the employment agreement will expire on October 1, 2022. The term will thereafter automatically extend for successive one-year periods, but Mr. Duhame's employment may at any time be terminate in accordance with provisions within the employment agreement.  Pursuant to his employment agreement, Mr. Duhame will receive an annual base salary of $200,000.  Mr. Duhame at his option may defer base salary which will accrue interest at 10% per annum, and shall, upon Mr. Duhame's written request to the Board, be convertible into options for shares of common stock of the Company on a quarterly basis, where the conversion shall be equal to 25% to the market price of the Company's shares at the time of the conversion, and where each option's strike price shall be at $.001 per share.

 

Mr. Duhame shall be eligible to participate in the Company's common stock incentive plan as in effect from time to time.  As of October 1, 2017, the Compensation Committee of the Board of Directors has granted Mr. Duhame, 250,000 shares of stock in the Company at par value of $.001 which shall be issued upon execution of the agreement, and 1,500,000 stock options at a purchase price of $.001 per share with a vesting schedule as follows: 25% of the options shall vest immediately upon the effective date, 25% of the options shall vest upon the Company reaching $1,000,000 in aggregate total sales revenue earned after the effective date, 25% of the options shall vest upon the Company reaching $2,000,000 in aggregate total sales revenue earned after the effective date, and the remaining unvested shares shall vest upon the Company reaching $3,000,000 in sales revenue earned after the Effective Date. The Company may grant Mr. Duhame additional stock options, restricted stock units or other awards under the Company's common stock incentive plan based on individual and Company performance criteria to be established by the Board.

 

Daniel Kryger

 

On February 1, 2018, the Company, entered into an employment agreement with Mr. Kryger. The term of the employment agreement will expire on February 1, 2023. The term will thereafter automatically extend for successive one-year periods, but Mr. Kryger's employment may at any time be terminate in accordance with provisions within the employment agreement.  Pursuant to his employment agreement, Mr. Kryger will receive an annual base salary of $120,000.  Mr. Kryger at his option may defer base salary which will accrue interest at 10% per annum, and shall, upon Mr. Kryger's written request to the Board, be convertible into options for shares of common stock of the Company on a quarterly basis, where the conversion shall be equal to 25% to the market price of the Company's shares at the time of the conversion, and where each option's strike price shall be at $.001 per share.

 

Mr. Kryger shall be eligible to participate in the Company's common stock incentive plan as in effect from time to time.  As of February 1, 2018, the Compensation Committee of the Board of Directors has granted Mr. Kryger, 200,000 shares of stock in the Company at par value of $.001 which shall be issued upon execution of the agreement, and 1,000,000 stock options at a purchase price of $.001 per share with a vesting schedule as follows: 25% of the options shall vest immediately upon the effective date, 25% of the options shall vest upon the Company reaching $1,000,000 in aggregate total sales revenue earned after the effective date, 25% of the options shall vest upon the Company reaching $2,000,000 in aggregate total sales revenue earned after the effective date, and the remaining unvested shares shall vest upon the Company reaching $3,000,000 in sales revenue earned after the Effective Date. The Company may grant Mr. Kryger additional stock options, restricted stock units or other awards under the Company's common stock incentive plan based on individual and Company performance criteria to be established by the Board.

 

 

  39  
 

 

 

 

Elements of Post-Termination Compensation and Benefits

 

Employment Agreements

 

The Company has employment agreements with the certain of our executive officers. The employment agreements provide for certain payments and benefits to the executive officer upon the executive officer's separation from us as described below in "Potential Payments Upon Termination or Change in Control".

 

Change in Control Provisions for Equity Awards

 

Change in Control Provisions in the Employment Agreement .

 

If, upon or within one year of a Change of Control occurring at any time during the employment term, the Company or a succeeding entity terminates Robert Doherty, Robert Switzer, Derek Duhame and Daniel Kryger without Cause or Executive terminates his employment for Good Reason , the Company or the succeeding entity's obligation to Executive shall be (i) unpaid Base Salary, bonus and benefits accrued up to the effective date of termination, (ii) if there is no unpaid bonus earned for the year of termination, an amount equal to the product of 100% of Executive's Base Salary multiplied by a fraction, the numerator of which is the number of days he is employed by the Company during the year in which the termination occurs and the denominator of which is 365 and, if the date of termination occurs prior to the date on which the annual bonus, if any, for the immediately preceding year would otherwise be paid, an amount equal to the annual bonus that would have been paid to Executive for such immediately preceding year, based on the actual achievement of applicable performance goals and without regard to whether Executive is employed on the date the bonus otherwise would have been paid, (iii) a lump sum payment equal to Executive's then-current Base Salary for a period of thirty-six (36) months, and (iv) if Executive is eligible for and timely elects COBRA coverage for health insurance coverage, payment of Executive's COBRA premiums for health insurance coverage for himself and his eligible dependents for a period of up to eighteen (18) months, payments to be made on a monthly basis when the premiums are due, and in the event of the death of Executive before the expiration of such eighteen (18)-month period, the Company shall, for the remainder of such period, continue to pay the COBRA premiums for the Executive's dependents (including his spouse, if any) who were receiving COBRA coverage at the time of his death. In the event of a without Cause Change of Control termination or a without Good Reason Change of Control termination, each as described herein, the payments in this Section 7(a) shall be in lieu of, and not in addition to, any severance pay or benefits set forth in Sections 6(b) or 6(c), whichever may apply. Notwithstanding anything to the contrary contained herein or in any award agreement between Executive and the Company, in the event of a Change of Control (as defined below), (i) all unvested stock awards held by Executive, including stock options described in Section 3(b) and any other subsequent awards, shall become fully vested upon the Change of Control and, if applicable, immediately exercisable; (ii) each such award, and each already vested award described in Section 3(b), which is a stock option shall continue to be exercisable for the remainder of its term; and (iii) with respect to any award that is subject to the attainment of performance objectives or specified performance criteria, such performance objectives and criteria shall be deemed satisfied at the target level and any performance period shall be deemed to end as of the date of the Change of Control. As a condition to his receipt of the post-employment payments and benefits under this Section 7(a), other than the vesting of awards described in the preceding sentence, Executive must be in compliance with Section 5 of this Agreement, and must execute, return, not rescind and comply with a release of claims agreement in favor of the Company, related entities and individuals and the succeeding entity, within the timeframe and in a form to be prescribed by the Company or a succeeding entity. The severance amount described in clauses (ii) and (iii) of the first sentence of this paragraph shall be paid in a lump sum on the ninetieth (90th) day after the date of Executive's termination of employment (but in any event not later than March 15 of the year following the year in which Executive's employment terminates), provided that the Company has received the signed general release of claims agreement and Executive has not rescinded such agreement within the rescission period set forth in such agreement.

 

Potential Payments Upon Termination or Change in Control 

 

The employment agreements with  Robert Doherty, Robert Switzer, Derek Duhame and Daniel Kryger provide for certain payments and benefits upon a separation from us. To the extent applicable, "cause" and "good reason" are defined in the employment agreements.

 

 

  40  
 

 

 

 

Grants of Plan-Based Awards

 

The following table sets forth information regarding grants of awards to the Named Executive Officers during 2018.

 

 

Named Executive Officer 2017 2018
Robert Doherty      3,000,000                  -
James Kordenbrock                     -                  -
Robert Switzer      3,000,000                  -
Derek Duhame      1,850,000                  -
Daniel Kryger                     -   1,200,000

 

 

Name Grant Date All Other Stock Awards: Number of Shares of Stock or Units (#) All Other Options Awards: Number of Securities Underlying Options (#) Exercise or Base Price of Options Awards ($/share) Grant Date Fair Value of Stock and Options Awards Closing Price on Grant Date ($/share)
Robert Doherty - - - $                             - $                - $              -
             
Robert Switzer - - - $                             - $                - $              -
             
Derek Duhame - - - $                             - $                - $              -
             
Daniel Kryger 2/1/2018 200,000 - - $        0.162 $      0.162
  2/1/2018   1,000,000 $                     0.001 $        0.162 $      0.162
             
Akio Ariura - - - - - -

 

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth the equity awards outstanding at December 31, 2018 for each of the named executive officers:

 

Name Number of securities underlying unexercised options, exercisable Number of securities underlying unexercised options, unexercisable

Euity incentive

plan awards:

number of

securities

underlying unexercised unearned

Options exercise price ($)

Options

expiration

date

Number of shares or units of stock that have not vested (#) Market value of shares or units of stock that have not vested ($)

Equity

incentive

plan awards:

number

of

unearned

shares or

other

rights

that

have not

vested (#)

Equity incentive

plan awards:

market or payout value of

unearned

shares or

other rights

that have

not vested ($)

Robert Doherty, CEO and Director          231,250               92,500  -  $       0.001 August 3, 2021 -   -   -   -
              625,000          1,875,000  -  $       0.001 October 1, 2022   - -  -
            - - - -
Robert Switzer, Corporate Secretary              231,250               92,500 -  $       0.001 August 3, 2021 - - - -
              625,000          1,875,000    $       0.001 October 1, 2022 - - - -
            - - - -
                   
Derek Duhame, President             375,000           1,125,000 -  $       0.001 October 1, 2022 - - - -
                   
Daniel Kryger, Board Member             250,000             750,000   -  $       0.001 February 1, 2023     -   - -  
                   
Akio Ariura  - - -  -  - - - - -

 

 

 

  41  
 

 

 

Potential Payments upon Termination or Change-in Control

 

The employment agreements with current Named Executives may be terminated by giving the other party three-month advance notice. Other than as disclosed above, the Company does not have change-in-control arrangements with any of its current Named Executives, and the Company is not obligated to pay severance or other enhanced benefits to executive officers upon termination of their employment. Accordingly, there is no potential payments payable to our current Named Executive Officers upon termination or change-in control.

 

Director Compensation

 

Compensation paid to the Directors of the Company in 2018 is disclosed above.

 

All the compensation packages for each of directors are proposed by an executive and approved by the Board of Directors. Director compensation packages in 2019 may or will be adopted and will generally consist of cash compensation and long-term incentive equity compensation.

 

Limitation of Liability and Indemnification of Officers and Directors

 

Our bylaws provide for the indemnification of our present and prior directors and officers or any person who may have served at our request as a director or officer of another corporation in which we own shares of capital stock or of which we are a creditor, against expenses actually and necessarily incurred by them in connection with the defense of any actions, suits or proceedings in which they, or any of them, are made parties, or a party, by reason of being or having been director(s) or officer(s) of us or of such other corporation, in the absence of negligence or misconduct in the performance of their duties. This indemnification policy could result in substantial expenditure by us, which we may be unable to recoup.

 

Insofar as indemnification by us for liabilities arising under the Securities Exchange Act of 1934, as amended, may be permitted to our directors, officers and controlling persons pursuant to provisions of the Articles of Incorporation and Bylaws, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is against public policy and is, therefore, unenforceable. In the event that a claim for indemnification by such director, officer or controlling person of us in the successful defense of any action, suit or proceeding is asserted by such director, officer or controlling person in connection with the securities being offered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

At the present time, there is no pending litigation or proceeding involving a director, officer, employee or other agent of ours in which indemnification would be required or permitted. We are not aware of any threatened litigation or proceeding which may result in a claim for such indemnification.

 

 

 

  42  
 

 

 

 

ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following tables set forth information as of December 31, 2018, regarding the beneficial ownership of our common stock (a) by each stockholder who is known by the Company to own beneficially in excess of 5% of our outstanding common stock; (b) by each of the Company's officers and directors; (c) and by the Company's officers and directors as a group. Except as otherwise indicated, all persons listed below have (i) sole voting power and investment power with respect to their shares of common stock, except to the extent that authority is shared by spouses under applicable law, and (ii) record and beneficial ownership with respect to their shares of stock.

 

Title of Class Name and Address of Beneficial Owner Office, If Any Amount and Nature of Beneficial Ownership (1) Pecent of Class (6)
Common Stock Robert Doherty (2) CEO and Director                42,923,037 8.84%
Common Stock Robert Switzer (3) Secretary and Director                27,820,130 5.73%
Common Stock Daniel Kryger (4) Director and Director of Business Development                  7,553,730 1.56%
Common Stock Derek Duhame (5) President                18,160,182 3.74%
All Officers and Directors as a Group (4 persons named above)                  96,457,079 19.87%
Common Stock   5% Security Owners                                 - 0.0%
Total Shares Owned by Persons Named Above                    96,457,079 19.87%
         

 

(1)  Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities.

 

(2) Mr. Robert Doherty owns an aggregate of 40,602,088 shares common stock directly, 1,236,685 held by Advanced Materials Technology and holds 856,250 of vested options exercisable within the 60 days to purchase the Company's common stock.  In addition, included in the beneficial ownership amount are 228,014 shares held by immediate family members.

 

(3) Mr. Robert Switzer owns an aggregate of 21,856,953 shares common stock directly, 5,106,927 held by The AAA Switzer Trust and holds 856,250 of vested options exercisable within the 60 days to purchase the Company's common stock.

 

(4) Mr. Daniel Kryger owns an aggregate of 7,303,730 shares common stock directly and holds 250,000 of vested options exercisable within the 60 days to purchase the Company's common stock.

 

(5) Mr. Derek Duhame owns an aggregate of 17,785,182 shares common stock directly and holds 375,000 of vested options exercisable within the 60 days to purchase the Company's common stock.

 

(6)  The percent of class is based on shares of common stock issued and outstanding as of December 31, 2018.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

On August 3, 2016, the Company adopted The 2016 Qualified Employee Stock Incentive Plan (the "Incentive Plan") that provides for the issuance of stock or options to purchase stock to employees, consultants, and professionals at the discretion of the Board of Directors.  The Incentive Plan provides for the issuance of up to 1,500,000 or more shares and/or options to purchase shares in each fiscal and in any subsequent year the plan is extended. As of December 2017, three options to purchase 1,665,000 total shares of the Company common stock had been issued under the Incentive Plan, as follows:

 

 

  43  
 

 

 

 

Equity Compensation Plan Information

 

Plan Category   Number of securities to be issued upon the exercise of outstanding options, warrants and rights   Weighted average exercise price of outstanding options, warrants and rights   Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a))  
    (a)   (b)   (c)  
Equity compensation plans approved by security holders              
Equity compensation plans not approved by security holders       7,443,750     $ 0.001       50,000  
Total       7,443,750     $ 0.001       50,000  

 

Changes in Control

 

There are no arrangements known to us, including any pledge by any person of our securities, the operation of which may at a subsequent date result in a change in control of the Company.

 

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

 

Related Party Transactions

 

The Company has balances outstanding that are due from affiliated companies and payable to affiliated companies.  These amounts are payable upon demand and are non-interest bearing. 

 

Due from Related Parties

 

For the years ended December 31, 2018 and December 31, 2017, the Company had $0 and $11,890 that were due from related parties, respectively.

 

Due to Related Parties - Advanced Innovative Recovery Technologies, Inc.

 

During 2015, the Company entered into a license agreement for 10 years with Advanced Innovative Recovery Technologies, Inc., a stockholder of the Company.  In connection with the license, the Company issued 927,516 shares of common stock and agreed to pay $375,000 on each of June 30, 2016 and 2017.  The value of the common stock of $300,000 was based on recent sales of the Company's common stock.  The value of the license was $996,346 which equals the common stock issued that was valued at $300,000 plus $696,346, the present value of the two payments of $375,000.  The Company did not made the $375,000 payment due June 30, 2016; as a result, the Company had accrued interest on the unpaid balance at the rate of 5% per month.

 

The Company did not make the $375,000 payment due June 30, 2017; as a result, the Company had accrued interest on the unpaid balance at the rate of 5% per month.  The Company made a partial payment of $97,656 in April 2017 towards the outstanding balance.

 

On May 22, 2017, the Company entered into an agreement with Advanced Innovative Recovery Technologies, Inc. to, as of March 31, 2017, cancel its debt and acquire the formula. The Company issued 1,300,000 shares of its common stock with a total stated value equal to that of the agreed upon principal of $750,000 and penalties of $168,750, for a total agreed upon amount of $918,750.  In connection with this payment in full, during the year ended December 31, 2017, the Company recorded a gain on settlement of a liability of $42,855, which is included in other expenses and income in the accompanying CFS.

 

During 2018 and 2017, the overhead allocation charged to the Company from Advanced Innovative Recovery Technologies, Inc was $120,000 and $120,000, respectively for office space provided and other items such as minor warehouse space, office / warehouse supplies and resource function allocation. During 2017 and 2018, the amounts charged from Advanced Innovative Recovery Technologies, Inc, included in cost of goods sold was $161,661 and $168,415 of the total cost of goods sold as of December 31, 2018 and December 31, 2017, respectively. Amounts owed to Advanced Innovative Recovery Technologies, Inc as of December 31, 2018 and December 31, 2017 was $588,916 and $386,520, respectively.

 

 

  44  
 

 

 

 

Due to Related Parties – B3 LLC

 

B3, LLC is an inactive subsidiary of Advanced Innovative Recovery Technologies, Inc. Amount due to B3, LLC as of December 31, 2018 and December 31, 2017 was $5,507 and $5,507 respectively

 

Due to Related Parties - Officers

 

As December 31, 2018, the Company had $479,937 accrued salaries due to four officers, which had been netted against $56,269 notes receivable and advances to the officers that the Company is not expecting to be repaid but deducted from accrued salaries. Also, during the year ended December 31, 2018, 1,000,000 shares were issued for conversion of $375,000 of accrued salary and interest. The shares were value at $375,000 which represent a 25% discount to the closing stock price of $.005 at August 8, 2018.

 

As December 31, 2017, the Company had $146,250 accrued salaries due to three officers.

 

Related Party Transaction Policy

 

Our Company has a written Related Party Transaction Policy, or the Policy, for the purpose of describing the procedures used to identify, review, approve and disclose, if necessary, any transaction in which (i) the Company is a participant and (ii) a related person has or will have a direct or indirect material interest.

 

Once a related party transaction in which the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year has been identified, the Audit Committee must review the transaction for approval or ratification. In determining whether to approve or ratify a related party transaction, the Audit Committee shall consider all relevant facts and circumstances, including the following factors:

 

the benefits to the Company of the transaction;
the nature of the related party's interest in the transaction;
whether the transaction would impair the judgment of a director or executive officer to act in the best interest of the Company and its stockholders;
the potential impact of the transaction on a director's independence; and
any other matters the Audit Committee deems appropriate.

 

No director may participate in any discussion, approval or ratification of a transaction in which he or she is a related person.

 

Promoters and Certain Control Persons

 

We did not have any promoters at any time during the past five fiscal years.

 

 

 

  45  
 

 

 

 

ITEM 14.   PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Malone Bailey LLP,("MB") is our Principal Independent Registered Public Accountants engaged to audit our financial statements for the fiscal year ended December 31, 2018. MJF & Associates APC,("MJF") was our Principal Independent Registered Public Accountants engaged to audit our financial statements for the fiscal year ended December 31, 2017. The following table shows the fees that we paid or accrued for the audit and other services provided by MB and MJF for the fiscal years ended December 31, 2018 and 2017.

 

Audit Fees

 

This category consists of fees for professional services rendered by our principal independent registered public accountant for the audit of our annual financial statements, review of financial statements included in our quarterly reports and services that are normally provided by the independent registered public accounting firms in connection with statutory and regulatory filings or engagements for those fiscal years.

 

Fee Category   2018   2017
Audit Fee   $ 54,000     $ 53,750  
Audit-Related Fees   $ -     $ -  
Tax Fees   $ -     $ -  
All Other Fees   $ -     $ -  

 

Audit-Related Fees

 

This category consists of fees for assurance and related services by our principal independent registered public accountant that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under "Audit Fees". The services for the fees disclosed under this category include consultations concerning financial accounting and reporting standards.

 

Tax Fees

 

This category consists of fees for professional services rendered by our principal independent registered public accountant for tax compliance, tax advice, and tax planning.

 

All Other Fees

 

This category consists of fees for services provided by our principal independent registered public accountant other than the services described above.

 

Policy on Pre-Approval of Audit Services

 

The Audit Committee pre-approves all services, including both audit and non-audit services, provided by our independent registered public accounting firm. All audit services (including statutory audit engagements as required under local country laws) must be accepted by the Audit Committee before the audit commences.

 

Each year, management and the independent registered public accounting firm will jointly submit a pre-approval request, which will list each known and/or anticipated audit and non-audit service for the upcoming calendar year and which will include associated budgeted fees. The Audit Committee will review the requests and approve a list of annual pre-approved non-audit services.

 

All services provided by Malone Bailey LLP and MJF & Associates, APC during the fiscal years ended December 31, 2018 and 2017, respectively were pre-approved by the Audit Committee.

 

 

  46  
 

 

  

 

PART IV

 

ITEM 15.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a) The following consolidated financial statements are filed as a part of this Form 10-K:

 

(i) Reports of Independent Registered Public Accounting Firms
(ii) Consolidated Balance Sheets as of December 31, 2018 and 2017
(iii) Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2018 and 2017
(iv) Consolidated Statement of Stockholders' Equity for the years ended December 31, 2018 and 2017
(v) Consolidated Statements of Cash Flows for the years ended December 31, 2018 and 2017
(vi) Notes to Consolidated Financial Statements

 

(b) The following Exhibits are filed as part of this Annual Report on Form 10-K:

 

Exhibit No.   Description
3.1   Articles of Incorporation (incorporated herein by reference from Exhibit 3.1 to Registrant's Registration Statement on Form S-1 filed with the SEC on December 15, 2010)
3.2   Articles of Amendment to Articles of Incorporation ( incorporated herein by reference from Exhibit 3.4 to Registrant's Registration Statement on Form S-1 filed with the SEC on December 15, 2010)
3.3   Articles of Amendment of Amended Articles of Incorporation (incorporated herein by reference from Exhibit 3.1 to Registrant's Current Report on Form 8-K filed with the SEC on November 21, 2016) .
3.4   By-Laws (incorporated herein by reference from Exhibit 3.2 to Registrant's Registration Statement on Form S-1 filed with the SEC on December 15, 2010)
21.1   Subsidiaries of the registrant .*
31.1   Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .*
31.2   Certification of Principal Accounting Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .*
32.2   Certification of Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .*
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Labels Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document


  * Filed herewith

 

 

 

 

 

  47  
 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

  PUR NATURALS, INC  
       
  By: /s/  Robert Doherty  
  Robert Doherty  
  Chief Executive Officer  
  (Principal Executive Officer, Principal Financial and Accounting Officer)  
Date: July 24, 2019    

 

 

 

 

  48  
 

 

 

PURA NATURALS, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

Contents   Page
     
Reports of Independent Registered Public Accounting Firms   F-2 and F-3
     
Consolidated Balance Sheets as of December 31, 2018 and 2017   F-4
     
Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2018 and 2017   F-5
     
Consolidated Statements of Stockholders' Deficit for the years ended December 31, 2018 and 2017   F-6
     
Consolidated Statements of Cash Flows for the years ended December 31, 2018 and 2017   F-7
     
Notes to Consolidated Financial Statements    F-8

 

 

 

  F- 1  
 

 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

Pura Naturals, Inc.

 

Opinion on the financial statements

 

We audited the accompanying consolidated balance sheet of Pura Naturals, Inc. ("the Company") as of December 31, 2017 and the related statements of operations, stockholders' deficit, and cash flows for the year then ended and the related notes (collectively referred to as "financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017, and the results of its operations and cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis of Opinion

 

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

The accompanying consolidated financial statements were prepared assuming the Company will continue as a going concern. For the year ended December 31, 2017, the Company incurred a net loss of $4,979,910 and had negative cash flows from operations of $1,108,611. The Company may need to discontinue a portion or all of its operations if it is unsuccessful in generating positive cash flow or financing for our operations through the issuance of securities. These factors, among others, as discussed in Note 3 to the consolidated financial statements, raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 3. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

We have served as the Company’s auditor since 2017.

 

 

 

MJF & Associates

Los Angeles, California

April 16, 2017

 

 

 

 

 

 

 

 

  F- 2  
 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Shareholders and Board of Directors of

Pura Naturals, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Pura Naturals, Inc. and its subsidiary (collectively, the “Company”) as of December 31, 2018, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018, and the results of their operations and their cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern Matter

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency that raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

/s/ MaloneBailey, LLP

www.malonebailey.com

We have served as the Company's auditor since 2018.

Houston, Texas

July 24, 2019

 

 

 

  F- 3  
 

 

P URA NATURALS, INC

Consolidated Balance Sheets

 

         
    December 31,   December 31,
    2018   2017
         
ASSETS        
CURRENT ASSETS                
Cash   $ 29,777     $ 67,422  
Accounts receivable, net of allowance of $33,448 and $0     52,001       66,427  
Due from related parties     -       11,890  
Inventory     115,171       105,087  
Prepaid expenses and other current assets     106,010       109,430  
Total Current Assets     302,959       360,256  
OTHER ASSETS                
Intangible assets, net     657,950       755,682  
Total Other Assets     657,950       755,682  
TOTAL ASSETS   $ 960,909     $ 1,115,938  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT                
                 
CURRENT LIABILITIES                
Accounts payable   $ 496,213     $ 321,250  
Accrued expenses     822,622       226,273  
Due to related parties     594,423       392,037  
Deferred revenues     25,000       72,808  
Notes payable     103,722       -  
Convertible notes payable, net of discount of $272,633 and $506,237 as of December 31, 2018     775,690       781,901  
and December 31, 2017, respectively                
Derivative liabilities     1,209,150       897,968  
Total Current Liabilities     4,026,820       2,692,237  
TOTAL LIABILITIES     4,026,820       2,692,237  
                 
COMMITMENTS AND CONTIGENCIES                
                 
STOCKHOLDERS' DEFICIT                
Common stock: par value $0.001, 500,000,000 shares authorized;                
483,552,395 and 39,114,709 shares issued and outstanding, respectively, as of December 31, 2018 and December 31, 2017.     483,551       39,115  
Additional paid-in capital     10,362,669       5,710,270  
Accumulated deficit     (13,912,131 )     (7,325,684 )
TOTAL STOCKHOLDERS' DEFICIT     (3,065,911 )     (1,576,299 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 960,909     $ 1,115,938  
                 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  F- 4  
 

 

 

PURA NATURALS, INC

Consolidated Statements of Operations

 

    Years Ended
    December 31,
    2018   2017
         
         
Sales   $ 377,046     $ 451,381  
Cost of goods sold     247,636       286,875  
GROSS PROFIT     129,410       164,506  
                 
OPERATING EXPENSES                
Selling expense     375,938       73,747  
General and administrative     3,147,540       4,360,432  
Total Operating Expenses     3,523,478       4,434,179  
LOSS FROM OPERATIONS     (3,394,068 )     (4,269,673 )
OTHER INCOME (EXPENSE)                
Interest expense     (1,208,750 )     (1,399,860 )
Gain on debt extinguishment     -       42,855  
Change in fair value of derivative liabilities     (1,983,629 )     646,768  
Total Other Expense     (3,192,379 )     (710,237 )
LOSS BEFORE INCOME TAX PROVISION     (6,586,447 )     (4,979,910 )
Income tax provision     -       -  
NET LOSS     (6,586,447 )     (4,979,910 )
                 
NET LOSS PER COMMON SHARE                
Net loss per share                
BASIC AND DILUTED   $ (0.04 )   $ (0.14 )
                 
Weighted average common                
  shares outstanding                
BASIC AND DILUTED     173,303,001       35,407,320  
                 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  F- 5  
 

 

 

PURA NATURALS, INC

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ (DEFICIT)

 

    Common Stock       Paid-in   Accumulated   Stockholders'
    Shares   Amount   Capital   Deficit   Deficit
Balance, December 31, 2016     33,612,376     $ 33,612       1,956,536     $ (2,345,774 )   $ (355,626 )
                                         
Common stock issued for services     2,342,000       2,342       1,556,636               1,558,978  
Common stock issued for cash     142,868       143       224,357               224,500  
Fair value of options                     840,327               840,327  
Exercise of options     462,500       463       77,238               77,701  
Common stock issued for debt payment     1,300,000       1,300       869,700               871,000  
Common stock issued as inducement shares                     62,730               62,730  
Common stock to be issued             -                       85  
Conversion of convertible debt into equity     1,100,000       1,100       115,262               116,362  
Common stock issued for accounts payable     69,965       70       7,484               7,554  
Common shares issued as inducement shares for convertible debt     85,000       85       -                  
Net loss                             (4,979,910 )     (4,979,910 )
Balance, December 31, 2017     39,114,709     $ 39,115     $ 5,710,270     $ (7,325,684 )   $ (1,576,299 )
                                         
Common stock issued for notes principal and accrued interest conversions     343,854,353       343,853       770,194               1,114,047  
Common stock issued for cash     83,333       83       4,917               5,000  
Common stock issued to extend due date of convertible debt     300,000       300       25,200               25,500  
Common stock issued for services     100,200,000       100,200       307,200               407,400  
Fair value of options                     1,139,462               1,139,462  
Derivative liabilities extinguished on conversion                     2,405,426               2,405,426  
Net loss                             (6,586,447 )     (6,586,447 )
Balance at December 31, 2018     483,552,395     $ 483,551     $ 10,362,669     $ (13,912,131 )   $ (3,065,911 )

  

The accompanying notes are an integral part of these consolidated financial statements.

 

 

  F- 6  
 

 

 

PURA NATURALS, INC

Consolidated Statements of Cash Flows

 

    Years Ended
    December 31,
    2018   2017
         
OPERATING ACTIVITIES:                
Net loss   $ (6,586,447 )   $ (4,979,910 )
Adjustments to reconcile net loss to net cash used                
  in operating activities:            

 

 

 
Imputed interest     -       835  
Amortization of intangible assets     100,257       101,742  
Amortization of debt discount     1,003,083       1,181,750  
Bad debt expense     33,448       -  
Change in fair value of derivative liabilities     1,983,629       (646,769 )
Fair value of options vested     1,139,462       918,028  
Common stock issued for services     407,400       1,566,531  
Common stock issued for convertible note due date extension     25,500       -  
Penalty interest resulted in principal increase     59,520       -  
Gain on debt extinguishment     -       (42,855 )
Convertible note issued for commitment fee     -       330,000  
Changes in operating assets and liabilities:                
Accounts receivable     (19,022 )     (20,636 )
Inventory     (10,084 )     (105,087 )
Due from related parties     11,890       20,018  
Due to related parties     202,386       425,705  
Prepaid expenses and other current assets     203,420       (93,680 )
Accounts payable     174,963       94,196  
Accrued expenses     629,061       (4,729 )
Deferred income     (47,808 )        
Deferred salary             146,250  
                 
                 
Cash Used in Operating Activities     (689,342 )     (1,108,611 )
                 
INVESTING ACTIVITIES:                
Payments for intangible assets     (2,525 )     (5,705 )
Cash Used in Investing Activities     (2,525 )     (5,705 )
                 
FINANCING ACTIVITIES:                
Advance from related party     -       19,500  
Common shares to be issued as part of convertible debt     -       62,815  
Repayment of convertible debt     -       (78,000 )
Proceeds from note payable-Related Party     -       (52,645 )
Payments on notes payable     (27,278 )     (73,068 )
Proceeds from the issuance of convertible notes payable     548,000       1,009,250  
Proceeds from sale of common stock for cash     5,000       224,500  
Proceeds from notes payable     128,500       55,000  
    Net Cash Provided by Financing Activities     654,222       1,167,352  
NET CHANGE IN CASH     (37,645 )     53,036  
CASH AT BEGINNING OF PERIOD     67,422       14,386  
CASH AT END OF PERIOD   $ 29,777     $ 67,422  
                 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:                
Interest paid   $ 4,386     $ 265,617  
Income tax paid   $ -     $ -  
                 
Non-Cash Investing and Financing Activities:                
Expense & debt paid by third party on behalf of Company   $ -     $ 50,000  
Common stock issued for license   $ -     $ 871,000  
Increase in amount due to related party for license   $ -     $ 168,750  
Original Issue Discount   $ -     $ 95,250  
Common Stock to be issued as inducement shares for convertible debt   $ -     $ 85  
Common stock issued for notes principal and accrued interest conversions   $ 1,114,047     $ 116,362  
Debt discount for new issuances due to derivative feature of convertible note   $ 732,979     $ 1,405,766  
Derivative liability extinguished on conversion   $ 2,405,426     $ -  
Convertible note issued for prepaid service   $ 200,000     $ -  
                 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 



  F- 7  
 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

 

Note 1 - Organization and Basis of Presentation

 

Organization and Line of Business

 

Pura Naturals, Inc. (formerly Yummy Flies, Inc.) (The "Company" or "Pura - CO") was incorporated under the laws of the State of Colorado on December 26, 2005.  On November 17, 2016, the Company changed its name from Yummy Flies, Inc. to Pura Naturals, Inc.

 

Pura Naturals, Inc., ("Pura - DE") was incorporated on April 20, 2015 under the laws of the state of Delaware.  Prior to incorporating in Delaware, the Company was incorporated on October 21, 2013 under the laws of the state of Nevada as a limited liability company.  On June 30, 2015, the Company exchanged membership interests in the Nevada Corporation for common stock of the Pura - DE.

 

Effective July 18, 2016, the Company entered into that certain share exchange agreement by and among the Company, Pura - DE") and certain shareholders of Pura – DE  (the "PURA Shareholders").  Pursuant to the Share Exchange Agreement, the Company exchanged the outstanding common and preferred stock of Pura - DE held by the PURA Shareholders for shares of common stock of the Company.  At the closing date, Robert Lee, the holder of 30,536,100 shares of common stock, agreed to cancelation of such shares.  Other than Robert Lee, shareholders of Company common stock held 7,625,700 shares.  Also on the closing date, the Company issued 23,187,876 shares of common stock to the PURA shareholders.   In addition, shares issuable under outstanding options of Pura – DE will be exercisable into shares of common stock of the Company, pursuant to the terms of such instruments.  As a result of the share exchange agreement and the other transactions contemplated there under, Pura - DE became a wholly owned subsidiary of the Company.

 

The exchange of shares with Pura - DE was accounted for as a reverse acquisition under the purchase method of accounting since Pura - DE obtained control of the Company. Accordingly, the merger of Pura - DE into the Company was recorded as a recapitalization of Pura - DE, Pura - DE being treated as the continuing entity. The historical financial statements presented are the financial statements of Pura - DE. The share exchange agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the date of this transaction, the net liabilities of the legal acquirer, Pura - CO, were $20,040.

 

The Company is engaged in the marketing and sales of consumer products through the use of direct sales, brokers and distributors to wholesalers, mass merchandisers, retail stores and on the internet.

 

Note 2 – Summary of Significant Accounting Policies

 

Accounting Method

 

The Company's consolidated financial statements ("CFS") are prepared using the accrual method of accounting. The Company elected a fiscal year ending on December 31.

 

Reclassification

 

Certain amounts in the prior period financial statements were reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses.

 

Principles of Consolidation

 

The accompanying CFS include the accounts of the Company and its wholly-owned subsidiary, PURA - DE, and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP").  All significant intercompany transactions and balances were eliminated.

 

 

 

  F- 8  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reporting period.

 

The Company's significant estimates and assumptions include the fair value of financial instruments; allowance for doubtful accounts; and obsolescence; and interest rate; revenue recognized or recognizable; sales returns and allowances; valuation of derivative liabilities, valuation of options, income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

 

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.

 

Cash

 

Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. As of December 31, 2018 and 2017, the Company did not have any cash equivalents.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

The Company grants credit to customers under credit terms that it believes are customary in the industry and does not require collateral to support customer receivables. The Company currently does not provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Normal receivable terms vary from 30-90 days after the issuance of the invoice and typically would be considered past due when the term expires. Delinquent receivables are written off based on individual credit evaluation and specific circumstances of the customer.  The Company's allowance for doubtful accounts was $33,448 at December 31, 2018 and $0 at December 31, 2017, respectively.

 

Gross Profit

 

Gross profit is equal to product sales, net of allowances less cost of goods sold. Cost of goods sold is associated with sales of our products and includes direct costs associated with the purchase of components, and costs associated with the packaging, preparation, and shipment of the product.

 

Inventories

 

Inventories are valued at the lower of cost or net realizable value. Cost is determined on an average cost basis which approximates actual cost on a first-in, first out basis and includes raw materials, labor and manufacturing overhead.

 

At each balance sheet date, the Company evaluates its ending inventories for excess quantities and obsolescence.

 

 

 

 

  F- 9  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

The Company considers historical demand and forecast in relation to the inventory on hand, market conditions and product life cycles when determining obsolescence and net realizable value. Provisions are made to reduce excess or obsolete inventories to their estimated net realizable values. Once established, write-downs are considered permanent adjustments to the cost basis of the excess or obsolete inventories.

 

Components of Inventory   2018   2017
Finished goods   $ -     $ -  
Work in progress     -       -  
Raw materials   $ 115,171     $ 105,087  

 

Intangible Assets

 

Intangible assets consist of a license with a related party and amounts paid to obtain trademarks.  Intangible assets are amortized over 120 months.

 

Long-Lived Assets

 

The Company applies ASC Topic 360, Property, Plant, and Equipment , which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at December 31, 2018 and 2017, the Company believes there was no impairment of its long-lived assets.

 

Derivative Financial Instruments

 

The Company applies ASC 815-10, Derivatives and Hedging ("ASC 815-10"). Derivatives within the scope of ASC 815-10 must be recorded on the balance sheet at fair value ("FV"). During the year ended December 31, 2017, the Company issued convertible debentures and recorded derivative liabilities related to the embedded conversion feature of the convertible notes (See Note 7).

 

The Company determined the conversion feature of the convertible notes represents an embedded derivative since the Note is convertible into a variable number of shares upon conversion.  Accordingly, the Note is not considered to be conventional debt and the embedded conversion feature must be bifurcated from the debt host and accounted for as a derivative liability.

 

Therefore, the FV of the derivative instruments has been recorded as liabilities on the balance sheet with the corresponding amount recorded as discounts to the Notes. Such discounts will be accreted from the issuance date to the maturity date of the Notes.

 

The change in the FV of the derivative liabilities will be recorded in other income or expenses in the statement of operations at the end of each period, with the offset to the derivative liabilities on the balance sheet. The FV of the embedded derivative liabilities on the convertible notes were determined using a Black-Scholes-Merton options pricing model ("Black-Scholes") on the issuance date.

 

Revenue Recognition

 

The Company recognizes revenue from sales of consumer products to wholesalers, mass merchandisers and retail stores . In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (Topic 606) “Revenue from Contracts with Customers.” Topic 606 supersedes the revenue recognition requirements in Topic 605 “Revenue Recognition” (Topic 605). The new standard’s core principal is that an entity will recognize revenue at an amount that reflects the consideration to which the entity expects to be entitled in exchange for transferring good or services to a customer. The principals in the standard are applied in five steps: 1) Identify the contract(s) with a customer; 2) Identify the performance obligations in the contract; 3) Determine the transaction price; 4) Allocate the transaction price to the performance obligations in the contract; and 5) Recognize revenue when (or as) the entity satisfies a performance obligation.

 

 

 

  F- 10  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

ASU No. 2014-09, Revenue from Contracts with Customers ("Topic 606"), became effective for us on January 1, 2018. We applied the "modified retrospective" transition method for open contracts for the implementation of Topic 606. As sales are and have been primarily through distributors, and we have no significant post delivery obligations, this did not result in a material recognition of revenue on our accompanying CFS for the cumulative impact of applying this new standard. We made no adjustments to our previously-reported total revenues, as those periods continue to be presented in accordance with our historical accounting practices under Topic 605, Revenue Recognition.

 

Deferred Revenue

 

In some instances, the Company receives payments prior to delivery of its products, whereupon such revenues are deferred until the revenue recognition criteria are met.

 

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation . FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at FV at the grant date and recognize the expense over the employee's requisite service period. The Company recognizes in the statement of operations the grant-date FV of stock options and other equity-based compensation issued to employees and non-employees. There were 8,193,750 and 7,193,750 options outstanding as of December 31, 2018 and 2017, respectively.

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes . ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is "more likely than not" that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the "more likely than not" test, no tax benefit is recorded.

 

Basic and Diluted Earnings (Loss) Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share . Basic earnings per share ("EPS") is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive convertible shares and stock warrants were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

Based on the conversion prices in effect, the potentially dilutive effects of 7,383,750 and 1,763,750 warrants and options were not considered in the calculation of EPS as the effect would be anti-dilutive on December31, 2018 and December 31, 2017, respectively.

 

Based on the conversion prices in effect, the potentially dilutive effects of 533,312,441 and 29,316,095 due to convertible debt were not considered in the calculation of EPS as the effect would be anti-dilutive on December31, 2018 and December 31, 2017, respectively.

 

 

 

  F- 11  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

 

 

Recent Accounting Pronouncements

 

In July 2017, the Financial Accounting Standards Board ("FASB") issued ASU 2017-11 , Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features, II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. (the "ASU"). Part I of this ASU changes the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features and clarifies existing disclosure requirements. Part II does not have an accounting effect. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 with early adoption permitted. Part I of this ASU allows companies to exclude a down round feature when determining whether a financial instrument is considered indexed to the entity’s own stock. As a result, financial instruments with down round features may no longer be required to be accounted classified as liabilities. A company will recognize the value of a down round feature only when it is triggered, and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, such as warrants, an entity will treat the value of the effect of the down round, when triggered, as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. The Company adopted the ASU on January 1, 2019 and the adoption of this ASU did not have an impact on the CFS, as the Company’s financial instruments with down round features were tainted otherwise as liabilities.

 

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory , which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted.  The Company adopted the ASU on January 1, 2019 and the adoption of this ASU did not have an impact on the CFS, as the Company did not incur any intra-entity transfer of assets.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company adopted the ASU on January 1, 2019 and the adoption of this ASU did not an impact on the CFS, as the Company have not entered into any leasing arrangements

 

Management has considered all recent accounting pronouncements issued since and their potential effect on our financial statements. The Company's management believes that these recent pronouncements will not have a material effect on the Company's CFS.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future CFS.

 

 

NOTE 3 - GOING CONCERN AND MANAGEMENT PLANS

 

The Company's CFS for the year ended December 31, 2018, were prepared on a going concern basis which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has incurred losses from operations since its change of ownership, management and line of business on July 18, 2016. Management recognizes successful business operations and the Company's transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue adequate to support its cost structure. These conditions raise substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of uncertainties. 

 

 

 

  F- 12  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

The Company incurred losses from operations of $3,394,068 for the year ended December 31, 2018 and $,4,269,673 for the year ended December 31, 2017, and had an accumulated deficit of $13,912,131 at December 31, 2018. In addition, the Company used cash in operating activities of $689,342 for the year ended December 31, 2018. These factors raise substantial doubt about the Company's ability to continue as a going concern.

 

While the Company is attempting to establish an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern, the Company's cash position may not be adequate to support the Company's daily operations. Management intends to raise additional funds by seeking equity and/or debt financing; however there can be no assurances that it will be successful in those efforts. The ability of the Company to continue as a going concern is dependent upon the Company's ability to obtain financing, further implement its business plan, and generate revenues.

 

There are significant risks and uncertainties which could negatively affect the Company's operations. These are principally related to (i) the absence of a distribution network for the Company's products, (ii) the absence of any significant commitments or firm orders for the Company's products. The Company's limited sales to date for the Company's products make it impossible to identify any trends in the Company's business prospects. Accordingly, there can be no assurance that we will be able to pay obligations which we may incur in the future.

 

The Company's only sources of additional funds to meet continuing operating expenses, fund additional development and fund additional working capital are through the sale of securities and/or debt instruments. We are actively seeking additional debt or equity financing, but no assurances can be given that such financing will be obtained or what the terms thereof will be. The Company may need to discontinue a portion or all of our operations if the Company is unsuccessful in generating positive cash flow or financing for the Company's operations through the issuance of securities.

 

The audited financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Note 4 – Intangible Assets

 

The following are the details of intangible assets at December 31, 2018 and 2017:

 

    December 31,   December 31,
    2018   2017
License   $ 996,346     $ 996,346  
Trademarks     13,055       10,530  
      1,009,401       1,006,876  
Less accumulated amortization     (351,451 )     (251,194 )
    $ 657,950     $ 755,682  
                 

 

Amortization expense for 2018 and 2017 was $100,257 and $99,635, respectively.

 

The following summarizes estimated future amortization expense as of December 31, 2018 related to intangible assets:

 

 

 

 

  F- 13  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

 

 

Years ending December 31,    
  2019     $ 100,883  
  2020       100,883  
  2021       100,883  
  2022       100,883  
  2023       100,883  
  Thereafter       153,535  
        $ 657,950  

 

Note 5 –Related Party Transactions

 

The Company has balances outstanding that are due from affiliated companies and payable to affiliated companies.  These amounts are payable upon demand and are non-interest bearing. 

 

Due from Related Parties

 

For the years ended December 31, 2018 and December 31, 2017, the Company had $0 and $11,890 that were due from related parties, respectively.

 

Due to Related Parties - Advanced Innovative Recovery Technologies, Inc.

 

During 2015, the Company entered into a license agreement for 10 years with Advanced Innovative Recovery Technologies, Inc., a stockholder of the Company.  In connection with the license, the Company issued 927,516 shares of common stock and agreed to pay $375,000 on each of June 30, 2016 and 2017.  The value of the common stock of $300,000 was based on recent sales of the Company's common stock.  The value of the license was $996,346 which equals the common stock issued that was valued at $300,000 plus $696,346, the present value of the two payments of $375,000.  The Company did not made the $375,000 payment due June 30, 2016; as a result, the Company had accrued interest on the unpaid balance at the rate of 5% per month.

 

The Company did not make the $375,000 payment due June 30, 2017; as a result, the Company had accrued interest on the unpaid balance at the rate of 5% per month.  The Company made a partial payment of $97,656 in April 2017 towards the outstanding balance.

 

On May 22, 2017, the Company entered into an agreement with Advanced Innovative Recovery Technologies, Inc. to, as of March 31, 2017, cancel its debt and acquire the formula. The Company issued 1,300,000 shares of its common stock with a total stated value equal to that of the agreed upon principal of $750,000 and penalties of $168,750, for a total agreed upon amount of $918,750.  In connection with this payment in full, during the year ended December 31, 2017, the Company recorded a gain on settlement of a liability of $42,855, which is included in other expenses and income in the accompanying CFS.

 

During 2018 and 2017, the overhead allocation charged to the Company from Advanced Innovative Recovery Technologies, Inc was $120,000 and $120,000, respectively for office space provided and other items such as minor warehouse space, office / warehouse supplies and resource function allocation. During 2017 and 2018, the amounts charged from Advanced Innovative Recovery Technologies, Inc, included in cost of goods sold was $161,661 and $168,415 of the total cost of goods sold as of December 31, 2018 and December 31, 2017, respectively. Amounts owed to Advanced Innovative Recovery Technologies, Inc as of December 31, 2018 and December 31, 2017 was $588,916 and $386,520, respectively.

 

Due to Related Parties – B3 LLC

 

B3, LLC is an inactive subsidiary of Advanced Innovative Recovery Technologies, Inc. Amount due to B3, LLC as of December 31, 2018 and December 31, 2017 was $5,507 and $5,507 respectively

 

 

  F- 14  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

Due to Related Parties - Officers

 

As December 31, 2018, the Company had $479,937 accrued salaries due to four officers, which had been netted against $56,269 notes receivable and advances to the officers that the Company is not expecting to be repaid but deducted from accrued salaries.

 

As December 31, 2017, the Company had $146,250 accrued salaries due to three officers.

 

 

Note 6 - Fair Value Measurement

 

Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures , requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments , defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FVs because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

· Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

· Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

 

· Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the FV measurement.
·

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity , and FASB ASC Topic 815, Derivatives and Hedging

 

The Company uses Level 3 inputs for its valuation methodology for its derivative liability as its FV was determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company's derivative liability is adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.

 

The Company held certain financial instruments that are measured at fair value on a recurring basis. These consisted of convertible debt totaling $1,048,323 and $1,288,138 at December 31, 2018 and December 31, 2017 respectively, with a derivative liability totaling $1,195,478 and $897,968 at December 31, 2018 and December 31, 2017, respectively, which are categorized as Level 3. In addition, derivative liability of $13,672 and $0 was recorded for outstanding warrants for the year ended December 31, 2018 and December 31, 2017, respectively, which are categorized as Level 3.

 

The related loss on change in fair value of derivatives totaled $1,983,629 for the year ended December 31, 2018 and a related gain on the change in fair value of derivatives of $646,768 for the year ended December 31, 2017.

 

 

Note 7 -  Derivative Liabilities

 

During the year ended December 31, 2018, the Company identified conversion features embedded within its convertible debt. The Company has determined that the conversion feature of the convertible note represents an embedded derivative since the Note is convertible into a variable number of shares upon conversion. Accordingly, the Note is not considered to be conventional debt and the embedded conversion feature must be bifurcated from the debt host and accounted for as a derivative liability. Due to the lack of available common shares for all conversions, convertible notes with a fixed conversion price as well as warrants were categorized as a derivative.

 

Therefore, the FV of the derivative instruments was recorded as liabilities on the balance sheet with the corresponding amount recorded as discounts to the Notes. Such discounts will be accreted from the issuance date to the maturity date of the Notes. The change in the FV of the derivative liabilities will be recorded in other income or expenses in the statement of operations at the end of each period, with the offset to the derivative liabilities on the balance sheet. The FV of the embedded derivative liabilities on the convertible notes were determined using the Black-Scholes valuation model on the issuance dates with the assumptions in the table below.

 

 

 

  F- 15  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

The FV of the Company's derivative liabilities at and during the year ended December 31, 2018 and December 31, 2017 is as follows:

 

Derivative liability balance, December 31, 2016   $ -  
Issuance of derivative liability     1,611,351  
Derivative liability associated with repaid convertible notes     (66,615 )
Change in derivative liability     (646,768 )
Derivative liability balance, December 31, 2017     897,968  
Discount on debt     732,979  
Reclass to equity due to conversions     (2,405,426 )
Fair value mark to market adjustments     1,983,629  
Derivative liability balance, December 31, 2018   $ 1,209,150  
         

 

The FV's at the commitment dates and re-measurement dates for the convertible debt and warrants treated as derivative liabilities are based upon the following estimates and assumptions made by management for the year ended December 31, 2018 and December 31, 2017.:

 

  2018 2017
Risk free rate 1.96% - 2.70% 1.46% - 1.76%
Volatility 93% - 455% 103% - 156%
Conversion/Exercise Price $0.0016 - $.0093 $0.035 - $0.1825
Dividend rate 0% 0%
Term (Years) 0.0027 - 2.92 0.02 - 0.96
Stock Price $0.003 - $0.043 $0.07 - $1.62

 

 

  F- 16  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

Note 8 – Convertible Notes Payable

 

Convertible Promissory Note

 

On April 7, 2017, the Company issued to an accredited investor an secured Convertible Promissory Note (the "April Note") of $570,000 that matured on January 7, 2018. T he failure to pay principal and interest as scheduled represents an event of default under the terms of the Note. However, the holder of the Note has not declared a default. Robert Doherty and Robert Switzer each pledged 250,000 (500,000 total) of common shares as collateral for this note

 

The Company will receive the $570,000 in three tranches as follows:

 

(1) $200,000 upon signing of the Convertible Promissory Note, the Securities Purchase Agreement and Registration Rights Agreement of which $50,000 may be sent to the Company's auditor to complete the audit for the fiscal year ended December 31, 2016);

 

(2) $150,000 upon filing of a registration statement and receipt of up to $10,000,000 shares of the Company's common stock issuable under the Securities Purchase Agreement; and

 

(3) $150,000 upon the registration statement becoming effective.

 

A registration statement was filed on July 12, 2017, but did not become effective.. The Company received the second tranche of $150,000.

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the Convertible Promissory Note converted a portion of the note as follows:

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

November 2, 2017             300,000  $       54,750  $         0.1825
November 21, 2017             300,000  $       23,250  $         0.0775
December 11, 2017             500,000  $       38,363  $         0.0767
January 17, 2018             500,000  $       31,875  $         0.0638
January 31, 2018             500,000  $       31,875  $         0.0638
March 16, 2018             500,000  $       20,325  $         0.0407
April 19, 2018             500,000  $       11,250  $         0.0225
May 7, 2018             936,640  $       17,562  $         0.0188
May 22, 2018          1,000,000  $       12,225  $         0.0122
June 5, 2018          1,000,000  $       11,700  $         0.0117
June 18, 2018          1,000,000  $       11,800  $         0.0118
July 6, 2018          1,000,000  $         9,300  $         0.0093
July 23, 2018          1,900,000  $       10,260  $         0.0054
November 1, 2018          5,100,000  $       17,212  $         0.0034
         15,036,640         301,747  
       

 

 

  F- 17  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

As of December 31, 2018 and December 31, 2017, the total balance of the Convertible Promissory Note was $97,254 and $282,638, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $76,254 and $233,638, original issue discount of $15,000 and $35,000 and debt issuance costs of $6,000 and $14,000, respectively. 

 

Pursuant to the terms of the Convertible Promissory Note, the Company is not required to make any payments on the Convertible Promissory Note until maturity, and no interest shall accrue except in default. Prepayment of the Convertible Promissory Note is permitted without penalty; however, the investor has the right to convert all or any portion of the balance of the Note beginning six months after the issuance date, at a conversion price per share of 75% of the lowest trading price during the valuation period or "look back" period immediately preceding and including the date of conversion (as defined and calculated pursuant to the Convertible Promissory Note). There is no minimum conversion price.

 

Should the Company default on the Note, the default interest rate shall be the lower of 18% or the highest rate permitted under applicable law. The date of conversion is also adjustable in accordance with the Note's terms in the event certain capital reorganization, merger, or liquidity events of the Company as further described in the Note.

 

Due to the potential adjustment in the conversion price associated with this Convertible Promissory Note payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability.  The embedded conversion feature was initially calculated to be $273,266 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the convertible note payable up to the face amount of the convertible note. The debt discount of $273,266 is being amortized over the term of the convertible note.  The Company recognized interest expense of $8,548 and 264,717 during the year ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense in the amount of $1,539 and $47,461 relating to the amortization of the original issue discount and debt issuance costs. The unamortized balance of original issue discount and debt issuance costs totaled $0 and $0 at December 31, 2018 and December 31, 2017, respectively. 

 

8% Promissory Note

 

On July 5, 2017, the Company issued an 8% unsecured Promissory Note ("July Note") in the amount of $220,000, with an Original Issue Discount of $20,000 and Debt Issuance Costs of $20,000 to an accredited investor. This promissory note was originally due and payable on January 6, 2018, plus the one-time interest charge of on the principal of 8%. The holder has the right to convert all or any part of the outstanding amount due under this Note into fully paid and non-assessable shares of Common Stock upon an event of default. The Company was assessed a penalty of $37,520 under Section 2(b) of the July Note where upon the occurrence of any event of default, the outstanding balance shall immediately and automatically increase to 120% of the outstanding balance immediately prior to the occurrence of the event of default. In addition, the Company was assessed a penalty of $10,000 under section 3(b)(iv) of the July Note where a penalty is assessed when the price of common stock is less than $0.01.

 

In connection with the July Note, the Company granted 85,000 shares of Common Stock to the investor as inducement shares. These shares were issued on February 5, 2018. These Common Stock were valued at the market share price of $0.739 per share and recorded interest expense of $62,815.

 

On January 17, 2018, the Company entered into an agreement with the holder to amend terms of the July Note. The due date of the July Note was amended to February 6, 2018 from the original due date of January 6, 2018, In exchange for the amendment the Company delivered 300,000 shares of Common Stock. These Common Stock were valued at the market share price of $0.085 per share and recorded interest expense of $25,500. If, on the date that is the six-month anniversary of the date of the second amendment ("True-Up Date"), the volume weighted average price of the Common Stock on the day immediately preceding the True-Up Date as reported on the Company's Principal Market is less than the closing price of the Common Stock on the date of the second amendment, the Company shall, within three trading days of the holder's provision of written notice, issue and deliver an additional number of duly and validly issued, fully paid and non-assessable shares of Common Stock equal to the quotient of $25,000 divided by the subsequent share price multiplied by 1.5, less the extension shares. As of July 31, 2018 (six month anniversary), the estimated number of shares to be issued is approximately 1,074,000 with a fair value of approximately $7,500 using the stock price on July 31, 2018.

 

  F- 18  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

On January 31, 2018, the Company entered into an agreement with the holder to further amend terms of the July Note. The due date of the July Note was extended to March 6, 2018 from the original due date of January 6, 2018. In exchange for the amendment the holder converted $50,000 of the outstanding balance of the July Note.

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the Convertible Promissory Note converted a portion of the note as follows:

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

February 5, 2018        1,388,889  $   50,000  $        0.0360
March 8, 2018        1,428,571  $   50,000  $        0.0350
April 18, 2018        2,000,000  $   21,000  $        0.0105
June 12, 2018        2,750,000  $   21,725  $        0.0079
July 3, 2018        2,750,000  $   21,313  $        0.0078
July 26, 2018        3,500,000  $   12,250  $        0.0035
August 6, 2018        3,500,000  $   10,500  $        0.0030
August 29, 2018       (2,750,000)  $  (21,725)  $        0.0079
August 30, 2018        5,500,000  $     8,800  $        0.0016
September 10, 2018        7,750,000  $   12,400  $        0.0016
September 18, 2018      11,000,000  $   17,600  $        0.0016
October 3, 2018      13,500,000  $   21,600  $        0.0016
October 12, 2018      15,250,000  $   36,599  $        0.0024
       67,567,460  $ 262,062  

 

During the year ended December 31, 2018, the Company incurred penalties of $47,520 under provisions of the convertible note which was added to the outstanding principal.

 

As of December 31, 2018 and December 31, 2017, the total balance of the Convertible Promissory Note was $5,458 and $220,000, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $5,458 and $180,000, original issue discount of $0 and $20,000 and debt issuance costs of $0 and $20,000, respectively. 

 

Due to the potential adjustment in the conversion price associated with the July Note is based on the Company's stock price, the Company determined the conversion feature is a derivative liability.  The embedded conversion feature was initially calculated to be $230,656 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the July Note payable up to the face amount of the convertible note with the excess of $50,656 being recorded as a financing cost.  The debt discount of $180,000 is being amortized over the term of the the July Note.  The Company recognized interest expense of $5,837 and $174,162 during the year ended December 31 2018 and December 31, 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense in the amount of $1,298 and $38,703 relating to the amortization of the original issue discount and debt issuance costs. The unamortized balance of original issue discount and debt issuance costs totaled $0 and $1,297 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the July Note in the amount of $,20,571 and $17,029 for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the July Note totaled $37,600 and $17,029 as of December 31, 2018 and December 31, 2017, respectively.

 

 

  F- 19  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

In connection with the convertible note, the Company granted 85,000 shares of common stock as inducement shares.  These common stock were valued at the market share price of $0.739 per share and recorded interest expense of $62,815 for the year ended December 31, 2017.

 

Convertible Promissory Note-Commitment Fee

 

On July 14, 2017, the Company issued an unsecured Convertible Promissory Note ("July Note #2) of $330,000, with an original issue discount of $30,000 to an accredited investor for commitment fee related to the convertible promissory note. The July Note #2 convertible note was due and payable on April 17, 2018.  The holder shall have the right to convert all or any part of the outstanding amount due under this Convertible Promissory Note into fully paid and non-assessable shares of Common Stock, at a conversion price per share of 65% of the low trade price of the common stock during 30 days preceding the date of the applicable conversion notice.

 

Pursuant to the terms of the Convertible Promissory Note, the Company is not required to make any payments on the July Note #2 until maturity, and no interest shall accrue except in default.

 

Due to the potential adjustment in the conversion price associated with the July Note #2 based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability.  The embedded conversion feature was initially calculated to be $369,485 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the July Note #2 payable up to the face amount of the July Note #2 with the excess of $69,485 being recorded as a financing cost.  The debt discount of $300,000 is being amortized over the term of the July Note #2. 

 

The Company recognized interest expense of $113,868 and $186,131 during the year ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense in the amount of $11,387 and $18,613 relating to the amortization of the original issue discount. The unamortized balance of original issue discount totaled $0 and $11,387 at December 31, 2018 and December 31, 2017, respectively.

 

As of December 31, 2018 and December 31, 2017, the total balance of the Convertible Promissory Note was $330,000 and $330,000, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $300,000 and $300,000 and debt issuance costs of $30,000 and $30,000, respectively. 

 

12 % Convertible Note

 

On September 20, 2017, the Company issued a 12% unsecured Convertible Note ("September Note #2) of $75,000, with an original issue discount of $4,500 and Debt Issuance Costs of $3,000 to an accredited investor. The September Note #2 was due and payable on September 20, 2018. The holder shall have the right to convert all or any part of the outstanding amount due under this 12% Convertible Note into fully paid and non-assessable shares of common stock.

 

The conversion price hereunder shall equal the lower of: (i) the closing sale price of the common stock on the principal market on the trading day immediately preceding the closing date, and (ii) 50% of either the lowest sale price for the common stock on the principal market during the twenty (20) consecutive trading days including and immediately preceding the conversion date, or the closing bid price, whichever is lower

 

Due to the potential adjustment in the conversion price associated with the September Note #2 is based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability.  The embedded conversion feature was initially calculated to be $100,798 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the convertible note payable up to the face amount of the convertible note with the excess of $33,298 being recorded as a financing cost.  The debt discount of $67,500 is being amortized over the term of the 12% Convertible Note.  The Company recognized interest expense of $48,637 and $18,863 during the year ended December 31 2018 and 2017, respectively for the amortization of the debt discount for the note.

 

 

  F- 20  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense in the amount of $5,404 and $2,096 relating to the amortization of the original issue discount and debt issuance costs. The unamortized balance of original issue discount and debt issuance costs totaled $0 and $5,404 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the Convertible Note in the amount of $5,750 and $2,515, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the Convertible Note totaled $0 and $2,515 as of December 31, 2018 and September 30, 2017, respectively.

 

The Company was assessed a penalty of $12,000 under Section 1.2(C) of the September Note #2 where if delivery of the common stock issuable upon the conversion of the September Note #2 is not delivered within three business days of receipt of a notice of conversion.

 

As of December 31, 2018 and December 31, 2017, the total balance of the Convertible Promissory Note was $0 and $75,000, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $0 and $67,500 and debt issuance costs and original issue discount of $0 and $7,500, respectively. 

 

12 % Convertible Promissory Note

 

On September 12, 2017, the Company issued a 12% unsecured Convertible Promissory Note ("September Note #1) of $160,500, with debt issuance costs of $10,500 to an accredited investor. This September Note #1 was due and payable on September 12, 2018. The Holder shall be entitled to convert all of the outstanding and unpaid principal and accrued interest of this Note into fully paid and non-assessable shares of common stock in accordance with the stated conversion price commencing on the date that is 180 days from the issuance date.

 

The conversion price hereunder shall be 50% discount to the lowest trading price during the previous 20 trading days to the date of a conversion notice.

 

Due to the potential adjustment in the conversion price associated with this convertible note payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability.  The embedded conversion feature was initially calculated to be $251,454 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the convertible note payable up to the face amount of the convertible note with the excess of $101,454 being recorded as a financing cost.  The debt discount of $150,000 is being amortized over the term of the convertible note.  The Company recognized interest expense of $104,795 and 45,205 during the year ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $7,336 and $3,164 relating to the amortization of the original issue discount and debt issuance costs. The unamortized balance of debt issuance costs totaled $0 and $7,336 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 12% Convertible Promissory Note of $12,084 and $5,804, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 12% Convertible Promissory Note totaled $17,889and $5,804 as of December 30, 2018 and December 31, 2017, respectively

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the Convertible Promissory Note converted a portion of the note as follows:

 

 

 

  F- 21  
 

 

  

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

March 27, 2018          1,000,000  $       25,750  $          0.0258
April 19, 2018          2,141,249  $       22,804  $          0.0106
July 6, 2018          2,205,759  $       17,095  $          0.0078
July 27, 2018          4,068,841  $       14,241  $          0.0035
September 4, 2018          4,704,366  $         8,468  $          0.0018
September 18, 2018          9,840,492  $       15,745  $          0.0016
October 3, 2018          5,039,293  $         8,063  $          0.0016
         29,000,000  $     112,166  
       

 

As of December 31, 2018 and December 31, 2017, the total balance of the September Note #2 was $48,335 and $160,500, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $48,335 and $150,000 and debt issuance costs of $0 and $10,500, respectively. 

 

8 % Convertible Promissory Note

 

On October 23, 2017, the Company issued an 8% unsecured Convertible Promissory Note ("October Note") of $95,000, with debt issuance costs of $14,250 and original issue discount of $2,000 to an accredited investor. The October Note was due and payable on October 23, 2018. The holder shall be entitled to convert at any time, all of the outstanding and unpaid principal and accrued interest of the October Note into fully paid and non-assessable shares of common stock in accordance with the stated conversion price.

 

The conversion price hereunder shall be 55% discount to the lowest trading price during the previous 15 trading days to the date of a conversion notice.

 

Due to the potential adjustment in the conversion price associated with the October Note is payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability.  The embedded conversion feature was initially calculated to be $129,589 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the convertible note payable up to the face amount of the convertible note with the excess of $50,839 being recorded as a financing cost.  The debt discount of 78,839 is being amortized over the term of the October Note.  The Company recognized interest expense of 63,952 and 14,887 during the year ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $13,178 and $3,072 relating to the amortization of the original issue discount and debt issuance costs. The unamortized balance of debt issuance costs and original issue discount totaled $0 and $13,178 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the October Note of $4,035 and $1,437, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 8% Convertible Promissory Note totaled $0 and $1,437 as of December 30, 2018 and December 31, 2017, respectively.

 

 

 

  F- 22  
 

 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the October Note converted a portion of the note as follows:

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

May 10, 2018            1,380,379  $         20,000  $            0.0145
June 7, 2018            2,065,291  $         18,000  $            0.0087
June 22, 2018            2,058,329  $         17,000  $            0.0083
July 16, 2018            2,650,973  $         10,352  $            0.0039
July 26, 2018            3,501,049  $         13,479  $            0.0039
August 22, 2018            2,843,696  $           7,038  $            0.0025
September 7, 2018            6,059,494  $         10,665  $            0.0018
           20,559,211  $         96,534  
       

 

 

As of December 31, 2018 and December 31, 2017, the total balance of the October Note was $0 and $95,000, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $0 and $95,000, original issue discount of $0 and $2,000 and debt issuance costs of $0 and $14,250, respectively. 

 

4.25 % Convertible Promissory Note

 

On December 18, 2017, the Company issued a 4.25% unsecured Convertible Secured Redeemable Note ("December Note") of $125,000, with debt issuance costs of $16,250 and original issue discount of $750 to an accredited investor. The December Note was due and payable on October 23, 2018. The holder shall be entitled to convert at any time following six months after the issue date and from time to time thereafter to convert all or any amount of the principal face of the note into fully paid and non-assessable shares of common stock in accordance with the stated conversion price.

 

The conversion price hereunder shall be 61% discount to the lowest trading price during the previous 15 trading days to the date of a conversion notice.

 

Due to the potential adjustment in the conversion price associated with the December Note is based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability.  The embedded conversion feature was initially calculated to be $143,675 which is recorded as a derivative liability as of the date of issuance.  The derivative liability was recorded as a debt discount to the December Note payable up to the face amount of the December Note convertible note with the excess of $35,675 being recorded as a financing cost.  The debt discount of 108,000 is being amortized over the term of the December Note.  The Company recognized interest expense of 104,153 and 3,847 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $16,395 and $605 relating to the amortization of the original issue discount and debt issuance costs. The unamortized balance of debt issuance costs and original issue discount totaled $0 and $16,395 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the December Note of $5,016 and $189, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the December Note totaled $4,358 and $189 as of December 31, 2018 and December 31, 2017, respectively.

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the December Note converted a portion of the note as follows:

 

  F- 23  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

September 25, 2018         7,716,393  $      15,062  $        0.0020
October 4, 2018         4,224,286  $        8,063  $        0.0019
        11,940,679          23,125  

 

 

As of December 31, 2018 and December 31, 2017, the total balance of the December Note was $98,674 and $125,000, respectively.

 

As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $98,674 and $108,000, original issue discount of $0 and $750 and debt issuance costs of $0 and $16,250, respectively. 

 

12 % Convertible Promissory Note #1

 

On February 8, 2018, the Company issued a 12% unsecured Convertible Promissory Note #1 of $103,000 ("2018 Note #1"), with debt

issuance costs of $3,000 to an accredited investor. Net of debt issuance costs, the Company received $100,000. This 2018 Note #1 note was due and payable on November 20, 2018. The holder has the right from time to time, and at any time during the period beginning on the date which is 180 days following the date of the note and ending on the later of: (i) the maturity date and (ii) the date of payment of the default amount, each in respect of the remaining outstanding principal amount of this Note to convert all or any amount of the outstanding and unpaid principal amount of the 2018 Note #1 into fully paid and non-assessable shares of common stock.

 

Due to the potential adjustment in the conversion price associated with this 2018 Note #1convertible note payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $227,338 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as a debt discount to the 2018 Note #1 payable up to the face amount of the 2018 Note #1 Note convertible note with the excess of $127,338 being recorded as a change in fair value of derivative liability. The debt discount of $100,000 is being amortized over the term of the convertible note. The debt discount of 100,000 is being amortized over the term of the 2018 Note #1. 

 

The Company recognized interest expense of $100,000 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $3,000 and $0 relating to the amortization of debt issuance costs. The unamortized balance of debt issuance costs and original issue discount totaled $0 and $0 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 2018 Note #1 of $6,642 and $0, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 2018 Note #1

 

Accrued interest totaled $0 and $0 as of December 31, 2018 and December 31, 2017, respectively.

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the 2018 Note #1 converted a portion of the note as follows:

 

 

  F- 24  
 

 

  

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

Geneva Roth

Conversion

Date

Number of shares 

of common stock

Principal and

interest converted

Price per

share

  August 9, 2018            2,755,172  $           7,990  $           0.0029
  August 10, 2018            3,162,069  $            9,170  $           0.0029
  August 13, 2018           3,089,655  $           8,960  $           0.0029
  August 14, 2018           3,286,207  $           9,530  $           0.0029
  August 21, 2018           5,588,889  $         15,090  $           0.0027
  August 27, 2018           5,586,957  $         12,850  $           0.0023
  August 28, 2018           5,590,909  $         12,300  $           0.0022
  August 29, 2018           6,554,545  $         14,420  $           0.0022
  August 30, 2018           6,552,273  $          14,415  $           0.0022
  August 31, 2018           2,025,000  $           4,455  $           0.0022
             44,191,676              109,180  

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #1 was $0 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $0 and $10, original issue discount of $0 and $0 and debt issuance costs of $0 and $0, respectively. 

 

12 % Convertible Promissory Note #2

 

On March 5, 2018, the Company issued a 12% unsecured Convertible Promissory Note #2 of $103,000 ("2018 Note #2), with debt issuance costs of $3,000 to an accredited investor. Net of the debt issuance costs, the Company received $100,000. This 2018 Note #2 was due and payable on December 15, 2018. The holder has the right from time to time, and at any time during the period beginning on the date which is 180 days following the date of the note and ending on the later of: (i) the maturity date and (ii) the date of payment of the default amount, each in respect of the remaining outstanding principal amount of this 2018 Note #2 to convert all or any amount of the outstanding and unpaid principal amount of the 2018 Note #2 into fully paid and non-assessable shares of Common Stock. The conversion price is 61% of the average of the lowest two trading prices for the Common Stock during the ten trading day period ending on the latest complete trading day prior to the conversion date.

 

Due to the potential adjustment in the conversion price associated with this 2018 Note #2 payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $114,305 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as a debt discount to the 2018 Note #2 payable up to the face amount of the 2018 Note #2 with the excess of $14,305 being recorded as a change in fair value of derivative liabilities. The debt discount of $100,000 is being amortized over the term of the convertible note.

 

The Company recognized interest expense of $100,000 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $3,000 and $0 relating to the amortization of debt issuance costs. The unamortized balance of debt issuance costs and original issue discount totaled $0 and $0 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 2018 Note #2 of $6,180 and $0, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 2018 Note #2 totaled $0 and $0 as of December 31, 2018 and December 31, 2017, respectively.

 

  F- 25  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the 2018 Note #2 converted a portion of the note as follows:

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

September 7, 2018          6,550,000  $       14,410  $          0.0022
September 10, 2018          6,552,273  $       14,415  $          0.0022
September 11, 2018          7,737,500  $       24,760  $          0.0032
September 12, 2018          7,740,625  $       24,770  $          0.0032
September 13, 2018           3,732,051  $       14,555  $          0.0039
September 14, 2018          5,248,387  $       16,270  $          0.0031
        37,560,836           109,180  

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #2 was $0 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $0 and $0, original issue discount of $0 and $0 and debt issuance costs of $0 and $0, respectively. 

 

8 % Convertible Redeemable Note

 

On March 6, 2018, the Company issued a 8% unsecured Convertible Redeemable Note of $126,000 ("2018 Note #3"), with debt issuance costs of $6,000 to an accredited investor. Net of debt issuance costs, the Company received $120,000. This 2018 Note #3 is due and payable on March 6, 2019. The holder is entitled, at its option, at any time, to convert all or any amount of the principal face amount of this Note then outstanding into shares of Common Stock. The conversion price is 60% of the lowest trading prices for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date.

 

Due to the potential adjustment in the conversion price associated with this 2018 Note #3 payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $149,491 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as a debt discount to the 2018 Note #3 payable up to the face amount of the 2018 Note #3 with the excess of $29,491 being recorded as a change in fair value of derivative liabilities. The debt discount of 120,000 is being amortized over the term of the 2018 Note #3.

 

The Company recognized interest expense of $112,666 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $4,932 and $0 relating to the amortization of debt issuance costs. The unamortized balance of debt issuance costs totaled $1,068 and $0 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 2018 Note #3 of $4,937 and $0, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 2018 Note #3 totaled $0 and $0 as of December 31, 2018 and December 31, 2017, respectively.

 

 

 

 

  F- 26  
 

 

 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

During the years ended December 31, 2017 and December 31, 2018 the holder of the 2018 Note #3 converted a portion of the note as follows:

 

Conversion

Date

Number of shares

of common stock

Principal and

interest converted

Price per

share

September 18, 2018          6,273,401  $       12,045  $          0.0019
September 18, 2018          8,139,557  $       15,628  $          0.0019
September 26, 2018        11,412,156  $       21,911  $          0.0019
October 3, 2018        11,116,294  $       31,348  $          0.0028
October 9, 2018        11,058,397  $       31,185  $          0.0028
         47,999,805  $     112,117  
       

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #3 was $18,600 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $12,600 and $0, original and debt issuance costs of $6,000 and $0, respectively. 

 

0% Promissory Note

 

On November 15, 2018, the Company issued a 0% unsecured Promissory Note of $150,000 ("2018 Note #4"), with original issue discount of $20,000 to an accredited investor. Net of debt issuance costs, the Company received $130,000. This 2018 Note #4 is due and payable on August 15, 2019. The holder is entitled, at its option, at any time, to convert all or any amount of the principal face amount of this Note and accrued interest then outstanding into shares of Common Stock. The conversion price is the closing price of the Company's common stock on the date the note was funded.

 

Beginning on February 15, 2019 and continuing on the 15th of every consecutive calendar month for seven months, the Company shall make a cash payment of $21,429 to the Holder of the 2018 Note #4.

 

Due to the potential lack of available common share associated with this 2018 Note #4 payable based on the Company's stock price,

the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $108,268 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as

a debt discount to the 2018 Note #4 payable up to the face amount of the 2018 Note #4. The debt discount of 130,000 is being amortized over the term of the 2018 Note #4.

 

The original issue discount of 20,000 is being amortized over the term of the 2018 Note #4.

 

The Company recognized interest expense of 21,905 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $3,370 and $0 relating to the amortization of original issue discount costs. The unamortized balance of original issuance discount totaled $16,630 and $0 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 2018 Note #4 of $0 and $0, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 2018 Note #4totaled $0 and $0 as of December 30, 2018 and December 31, 2017, respectively.

 

 

  F- 27  
 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #4 was $150,000 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $130,000 and $0 and original issue discount costs of $20,000 and $0, respectively. 

 

8% Convertible Promissory Note

 

On October 8, 2018, the Company issued a 8% unsecured Convertible Promissory Note of $50,000 ("2018 Note #5"), with debt issuance costs of $1,000 to an accredited investor. Net of debt issuance costs, the Company received $49,000. This 2018 Note #5 is due and payable on April 8, 2019. The holder is entitled, at its option, at any time on or after the maturity date, to convert all or any amount of the principal face amount of this Note and accrued interest then outstanding into shares of Common Stock. The conversion price shall equal the lesser of (i) 80% multiplied by lowest trading price for the common stock during the five trading day period ending on the last complete trading day prior to the conversion date or (ii) $0.0065.

 

Due to the potential adjustment in the conversion price associated with this 2018 Note #5 payable based on the Company's stock price, the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $53,220 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as a debt discount to the 2018 Note #4 payable up to the face amount of the 2018 Note #4 with the excess of $3,220 being recorded as a change in fair value of derivative liabilities. The debt issuance cost of 1,000 is being amortized over the term of the 2018 Note #5.

 

The Company recognized interest expense of 22,077 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $462 and $0 relating to the amortization of original issue discount costs. The unamortized balance of debt issuance costs totaled $538 and $0 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 2018 Note #5 of $921 and $0, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 2018 Note #5 totaled $921 and $0 as of December 31, 2018 and December 31, 2017, respectively.

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #5 was $50,000 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $49,000 and $0 and debt issuance costs of $1,000 and $0, respectively. 

 

0% Convertible Promissory Note

 

On October 8, 2018, the Company issued a 0% unsecured Convertible Promissory Note of $200,000 ("2018 Note #6") for advertising services. This 2018 Note #6 is due and payable on April 8, 2019. The holder is entitled, at its option, at any time on or after the maturity date, to convert all or any amount of the principal face amount of this Note and accrued interest then outstanding into shares of Common Stock. The conversion price shall equal 90% multiplied by lowest trading price for the common stock during the five trading day period ending on the last complete trading day prior to the conversion date.

 

Due to the potential adjustment in the conversion price associated with this 2018 Note #6 payable based on the Company's stock price,

the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $184,979 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as

a debt discount to the 2018 Note #6payable.

 

The Company recognized interest expense of 100,077 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

 

  F- 28  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #6 was $200,000 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $200,000 and $0 and debt issuance costs of $0 and $0, respectively. 

 

The 2018 Note #6 was recorded as a prepayment of advertising costs and expensed over the term of the consulting contract. During the years ended December 31, 2018 and December 31, 2017, $94,382 and $0 was expensed as advertising costs, respectively.

 

8% Convertible Promissory Note

 

On October 8, 2018, the Company issued a 8% unsecured Convertible Promissory Note of $50,000 ("2018 Note #7"), with debt issuance costs of $1,000 to an accredited investor. Net of debt issuance costs, the Company received $49,000. This 2018 Note #7 is due and payable on April 8, 2019. The holder is entitled, at its option, at any time on or after the maturity date, to convert all or any amount of the principal face amount of this Note and accrued interest then outstanding into shares of Common Stock. The conversion price shall equal the lesser of (i) 80% multiplied by lowest trading price for the common stock during the five trading day period ending on the last complete trading day prior to the conversion date or (ii) $0.0065.

 

Due to the potential adjustment in the conversion price associated with this 2018 Note #7 payable based on the Company's stock price,

the Company determined the conversion feature is considered a derivative liability. The embedded conversion feature was initially calculated to be $53,220 which is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as

a debt discount to the 2018 Note #7 payable up to the face amount of the 2018 Note #7 with the excess of $3,220 being recorded as a

change in fair value of derivative liabilities. The debt issuance cost of 1,000 is being amortized over the term of the 2018 Note #7.

 

The Company recognized interest expense of 22,077 and $0 during the years ended December 31, 2018 and 2017, respectively for the amortization of the debt discount.

 

During the year ended December 31, 2018 and 2017 the Company recognized interest expense of $462 and $0 relating to the amortization of original issue discount costs. The unamortized balance of debt issuance costs totaled $538 and $0 at December 31, 2018 and December 31, 2017, respectively.

 

The Company recorded interest expense in connection with the 2018 Note #7 of $921 and $0, for the year ended December 31, 2018 and 2017, respectively. Accrued interest due under the 2018 Note #7 totaled $921 and $0 as of December 31, 2018 and December 31, 2017, respectively.

 

As of December 31, 2018 and December 31, 2017, the total balance of the 2018 Note #7 was $50,000 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $49,000 and $0 and debt issuance costs of $1,000 and $0, respectively. 

 

Other

 

As of now, the Company was unable to repay amounts due for the April Note, July Note, July Note #2, September Notes #1 and #2 , and 2018 Note #2, #4, #6, #7 and December note that were issued during the year ended December 31, 2017 and December 31, 2018. The inability to repay represents an event of default. The holders of the notes have not declared a default .

 

 

Note 9 – Notes Payable

 

On May 21, 2018, the Company into a loan agreement ("Loan #1) in the amount of $28,500. The repayment amount is $40,470 to be paid through a daily withdrawal from the Company's bank account of $165 per day. This loan is secured by the Company's all accounts, chattel paper, cash, deposits accounts, documents, equipment, general intangibles, instruments, inventory, or investment property.

 

The Company received $27,767, net of $733 in fees. Payments of $17,278 and $0 were made during the year ended December 31, 2018 and December 31, 2017, respectively.

 

 

 

  F- 29  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

Interest expense was $8,104 and $0 for the years ended December 31, 2018 and December 31, 2017, respectively.

 

As of December 31, 2018 and December 31, 2017, the total balance of the Loan #1was $11,222 and $0, respectively. As of December 31, 2018 and December 31, 2017 the balance comprised of principal note balance of $10,489 and $0 and fees of $733 and $0, respectively. 

 

On July 10, 2018, the Company issued 30% unsecured Promissory Note ("Loan #2) to an accredited investor in the amount of $50,000. The maturity date of Loan #2 was January 10, 2019. Progress payments of $5,000 each was due beginning on August 10, 2018 until December 31, 2018. During the year ended December 31, 2018, two payments were made.

 

Interest expense was $14,185 and $0 for the years ended December 31, 2018 and December 31, 2017, respectively.

 

Accrued interest at December 31, 2018 and December 31, 2017 was $14,185 and $0, respectively.

 

As of December 31, 2018 and December 31, 2017, the total balance of the Loan #2 was $40,000 and $0, respectively.

 

On August 10, 2018, the Company issued 0% unsecured Promissory Note ("Loan #3) in the amount of $52,500. The Company received $50,000, net of $2,500 in origination fees. The maturity date of Loan #3 was November 10, 2018. No payments were made during 2018.

 

Interest expense was $0 and $0 for the years ended December 31, 2018 and December 31, 2017, respectively.

 

Accrued interest at December 31, 2018 and December 31, 2017 was $0 and $0, respectively.

 

As of December 31, 2018 and December 31, 2017, the total balance of Loan #3 was $50,000 and $0, respectively.

 

As of now, the Company was unable to repay amounts due for Loans #1, Loan #2 and Loan #3 that were issued during the year ended December 31, 2018. The inability to repay represents an event of default. The holders of the notes have not declared a default.

 

 

Note 10 – Stockholders' Equity

 

Common stock

 

During 2018, the Company issued shares of common stock as follows:

 

200,000 shares was issued to one of the officers in connection with his employment agreement   The shares were valued at $32,400 based on the Company's stock price at the date of issuance;
1,000,000 shares were issued for conversion of $375,000 of accrued salary and interest. The shares were value at $375,000 which represent a 25% discount to the closing stock price of $.005 at August 8, 2018;
300,000 shares for note amendment; and
343,854,353 shares for convertible debt conversions into common stock.

 

During 2017, the Company issued shares of common stock as follows:

 

2,342,000 shares for services valued at $1,558,978.  The shares were valued based on the Company's stock price at the date of issuance;
142,868 shares for cash of $224,500;
462,500 shares upon the exercise of stock options;
1,300,000 shares for the conversion of a note payable into equity;
85,000 shares for inducement shares;
1,100,000 shares for the conversion of a convertible note payable into equity; and
69,965 shares utilized to pay accounts payable.

 

 

 

  F- 30  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

Stock options

 

The following is a summary of stock option activity:

 

  Options outstanding Weighted Average Exercise Price Weighted Average Remaining Life Agregate Intrinsic Value
Outstanding, December 31, 2016                                         1,156,250             0.001              4.59     2,554,156
Granted                                         6,500,000             0.001                 -                       -
Forfeited                                                       -                  -                     -                       -
Exercised                                          (462,500)             0.001                      -
Outstanding, December 31, 2017                                         7,193,750                  -                  4.58                    -
Exercisable and vested at December 31, 2017                                         1,763,750             0.001              4.66        128,754
Granted                                         1,000,000             0.001              5.00                    -
Forfeited                                                       -                  -                     -                       -
Exercised                                                       -                  -                     -                       -
Outstanding, December 31, 2018                                         8,193,750             0.001              3.70                    -
         
Exercisable and vested at December 31, 2018                                         2,383,750             0.001              3.54            3,974
         

1,000,000 options was issued during the year ended December 31, 2018 to Daniel Kryger in connection with his employment agreement. Upon execution of the employment agreement, Daniel Kryger was issued 1,000,000 stock options with a five year life and an exercise price of $.001. Twenty five percent vested upon execution of the employment agreement, twenty five percent will vest upon the Company reaching 1,000,000 in aggregate sales, twenty five percent will vest upon the Company reaching 2,000,000 in aggregate sales and twenty five percent will vest upon the Company reaching 3,000,000 in aggregate sales.

 

For options granted during 2018 and 2017 where the exercise price was less than the stock price at the date of the grant, the weighted-average FV of such options was $0.162 and $0.37 per share, respectively, and the weighted-average exercise price of such options was $0.001 and $0.001, respectively.  There was 0options and 5,000,000 warrants granted during 2018 and 6,500,000 options and 0 warrants granted during 2017 where the exercise price was equal to or greater than the stock price at the date of grant.

 

 

  F- 31  
 

 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

The FV of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $1,139,629 and $840,328 during 2018 and 2017, respectively. At December 31, 2018, the unamortized stock option expense was $1,182,616 which will be amortized to expense through October 1, 2021 and when certain milestone are met.

 

The assumptions used in calculating the FV of options granted using the Black-Scholes option- pricing model for options granted in 2018 and 2017 are as follows:

 

  2018 2017
Risk-free interest rate 1.92% 1.92%
Expected life of options 5.0 Years 5.0 Years
Expected volatility 182% 129%
Expected dividend yield 0% 0%

 

Warrants

 

In connection with 2018 Note 4, 5,000,000 warrants were issued on November 15, 2018. The warrants have a 3 year life and have an exercise price of $0.01. In addition, if the market price of one warrant share is greater than the exercise price, the holder may elect to receive warrant shares, in lieu of a cash exercise, equal to the value of the warrant determined as follows:

 

X = Y (A-B)/A

 

where X = the number of warrant shares to be issued to holder;

Y = the number of warrant shares that the holder elects to purchase under this warrant

A = the market price

B = exercise price

 

The warrants were valued for $23,347 and recorded as derivative and debt discount as the warrants were tainted by other convertible notes with variable conversion price. The intrinsic value of the 5,000,000 warrants as of December 31, 2018 is $0.

 

There were no outstanding warrants as of December 31, 2017.

 

The assumptions used in calculating the FV of warrants granted using the Black-Scholes option- pricing model for warrants granted in 2018 and 2017 are as follows:

 

 

  2018 2017
Risk-free interest rate 2.91% 0.00%
Expected life of options 3.0 Years 0
Expected volatility 225% 0%
Expected dividend yield 0% 0%
     

 

 

Note 11 - Concentrations

 

The Company had certain customers whose accounts receivable balances individually represented 10% or more of the Company's total accounts receivable, as follows:

 

 

 

  F- 32  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

 

For the year ended December 31, 2018, one customers accounted for 38% and one customer accounted for 14% of accounts receivable.  For the year ended December 31, 2017, one customer accounted for 30% and one customer account for 14% of accounts receivable.

 

The Company had certain vendors whose accounts payable balances individually represented 10% or more of the Company's total accounts payables.

 

For the year ended December 31, 2018, no vendor accounted for 10% of accounts payable.  For the year ended December 31, 2017, one vendor accounted for 10% of accounts payable.

 

Note 12 – Income Taxes

 

For tax purposes the Company has federal net operating loss ("NOL") carryovers of approximately $5,500,000 as of the year ended December 31, 2018, that are available to offset future taxable income. These NOL carryovers expire beginning in the year 2025. As a result of the Company's reorganization, as further described in Note 1, the NOL carryovers generated prior to the reorganization are limited by Section 382 of the Internal Revenue Code resulting in no NOL carryover for the years prior to reorganization.

 

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A full valuation allowance is established against all net deferred tax assets as of December 31, 2018 based on estimates of recoverability. While the Company has optimistic plans for its business strategy, it determined that such a valuation allowance was necessary given the current and expected near term losses and the uncertainty with respect to its ability to generate sufficient profits from its new business model.  Because of the impacts of the valuation allowance, there was no income tax expense or benefit for 2018 and 2017.

 

Significant components of the Company's deferred tax assets and liabilities are as follows:

 

  December 31,
  2018 2017
Deferred tax asset    
NOL carryforward  $       2,103,903  $    1,045,781
State income tax                          -           248,996
Stock compensation            (324,841)          (192,786)
Amortization of debt discount            (210,647)          (248,168)
Accrued interest                19,483              (6,253)
Gain on the settlement of liabilities                          -               9,000
Gain/loss of change in FV of derivatives            (416,562)          (135,821)
Bad debt expense                (7,024)                       -
   $       1,164,312  $       720,749
Valuation allowance         (1,164,312)          (720,749)
   $                   -      $                   -
     

 

 

 

  F- 33  
 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

A reconciliation of the differences between the effective and statutory income tax rates for year ended December 31, 2018 and 2017:

 

  2018   2017
   Amount Percent    Amount   Percent
Federal statutory rates  $       1,383,154 21.0%    $       1,045,781 21.0%
State income tax                          - 0.0%                248,996 5.0%
Stock compensation            (324,841) -4.9%              (192,786) -3.9%
Amortization of debt discount            (210,647) -3.2%              (248,168) -5.0%
Accrued interest                19,483 0.3%                  (6,253) -0.1%
Gain on settlement of liabilities                          - 0.0%                    9,000 -0.2%
Gain/loss of change in FV of derivatives            (416,562) -6.3%              (135,821) -2.7%
Bad debt expense                (7,024) -0.1%     0.0%
Valauation Allowance            (443,563) -6.7%              (720,749) -14.5%
   $                      - 0.0%    $                      - 0.0%
           

The Company recorded as of December 31, 2018 and 2017a valuation allowances of $1,164,312 and $720,749, respectively, as it believes that it is more likely than not that the deferred tax assets will not be realized in future years. Management has based its assessment on the Company's lack of profitable operating history. 

 

The Company periodically assesses whether it is more likely than not that it will generate sufficient taxable income to reduce the deferred tax assets. The realization of these assets is dependent upon generation of future taxable income sufficient to offset the related deductions and NOL carryovers within the applicable carryover periods as previously discussed. Management is unsure of the Company's ability to generate sufficient taxable income to realize the deferred tax assets. As such, the Company has recorded a valuation allowance for the entire net deferred tax asset.

 

The effective rate used for estimation of deferred taxes was 21% for the years ended December 31, 2018 and 2017.

 

The tax years that remain subject to taxing authorities' examination at December 31, 2018 are 2016 through 2018. The Company's policy is to classify penalties and interest associated with uncertain tax positions, if required, as a component of its income tax provisions. The Company annually conducts an analysis of its tax positions and has concluded that it has no uncertain tax positions as of December 31, 2018 and 2017.

 

The Company has net operating loss carry-forwards of approximately $5,500,000 as of December 31, 2018 Such amounts are subject to IRS code section 382 limitations and expire in 2030. The 2016 to 2018 tax years are still subject to audit.  As a limited liability company, through June 30, 2015, in the event of an examination of the Company's tax return for the periods prior to July 1, 2015, the tax liability of the members could be changed if an adjustment in the Company's income (loss) is ultimately sustained by the taxing authorities.

 

 

 

  F- 34  
 

 

 

 

 

PURA NATURALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2018 AND 2017

 

 

 

Note 12 – Commitments and Contingencies

 

From time to time, the Company is involved in routine litigation that arises in the ordinary course of business. There are no pending significant legal proceedings to which the Company is a party for which management believes the ultimate outcome would have a material adverse effect on the Company's financial position.

 

In lieu of cash of $60,345 for outstanding attorney invoices, 6,611,200 common shares are to be issued. A liability of $60,345 was recorded as of December 31, 2018 which will be offset when common shares are issued.

 

Note 13 - Subsequent Events

 

On January 31, 2019, Pura Naturals, Inc. (the “Company”) held an Annual Meeting of Stockholders (the “Annual Meeting”), at which the Company’s stockholders approved an amendment to the Company’s articles of incorporation (the “Certificate of Incorporation”) and adopted Company’s Amended and Restated Articles of Incorporation (the “Certificate of Amendment”) to increase the authorized shares of the Company’s common stock from 500,000,000 to 1,500,000,000 and to authorized a reverse split of the Company’s commons stock in a ratio of between 1 to 5 and 1 to 50 at the Board’s discretion.

 

On February 20, 2019, the holder of the December convertible note (see Note 8) converted $33,674 of principal and $1,947 of interest into equity. The conversion price was $0.002684 per share for a total of 13,271,643 common shares.

 

On February 20, 2019, the holder of the 2018 Note #3 (see Note 8) converted $18,600 of principal and $1,423 of interest into equity. The conversion price was $0.0018 per share for a total of 11,123,761 common shares.

 

On March 11, 2019, the holder of the September Note #1 (see Note 8) converted $37,311 of principal into equity. The conversion price was $0.0015 per share for a total of 24,873,931 common shares.

 

On March 22, 2019, the holder of the December convertible note (see Note 8) converted $25,000 of principal and $2,523 of interest into equity. The conversion price was $0.001708 per share for a total of 16,113,934 common shares.

 

On March 18, 2019, the holder of the April convertible note (see Note 8) converted $22,500 of principal into equity. The conversion price was $0.00225 per share for a total of 10,000,000 common shares.

 

On March 18, 2019, the Company issued pursuant to employment contracts 220,143,169 shares of common stock for deferred salary and accrued interest.

 

On April 1, 2019, the holder of the April convertible note (see Note 8) converted $14,775 of principal into equity. The conversion price was $0.0014775 per share for a total of 10,000,000 common shares.

 

On April 4, 2019, the holder of the 2018 Note #4 (see Note 8) converted $23,820 of principal into equity. The conversion price was $0.00075 per share for a total of 31,760,000 common shares.

 

On July 1, 2019, the Company issued 65,000,000 shares of common stock to various employees and consultants as compensation under the equity compensation plan.

 

 

 

  F- 35  
 

 

 

  

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  PUR NATURALS, INC  
       
  By: /s/  Robert Doherty  
  Robert Doherty  
  Chief Executive Officer  
  (Principal Executive Officer, Principal Financial and Accounting Officer)  
Date: July 24, 2019    

 

 

  F- 36